<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1532375</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2025.1532375</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Structural insights into SOD1: from in silico and molecular dynamics to experimental analyses of ALS-associated E49K and R115G mutants</article-title>
<alt-title alt-title-type="left-running-head">Hosseini Faradonbeh et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmolb.2025.1532375">10.3389/fmolb.2025.1532375</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hosseini Faradonbeh</surname>
<given-names>Seyed Mahdi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Seyedalipour</surname>
<given-names>Bagher</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2746528/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keivan Behjou</surname>
<given-names>Nasrin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rezaei</surname>
<given-names>Kimiya</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baziyar</surname>
<given-names>Payam</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hosseinkhani</surname>
<given-names>Saman</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1344077/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Molecular and Cell Biology</institution>, <institution>Faculty of Basic Science</institution>, <institution>University of Mazandaran</institution>, <addr-line>Babolsar</addr-line>, <country>Iran</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Biochemistry</institution>, <institution>Faculty of Biological Sciences</institution>, <institution>Tarbiat Modares University</institution>, <addr-line>Tehran</addr-line>, <country>Iran</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1326652/overview">Vladimir N. Uversky</ext-link>, University of South Florida, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/481726/overview">Laishram Rajendrakumar Singh</ext-link>, University of Delhi, India</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2910469/overview">Danish Idrees</ext-link>, University of Iowa Healthcare, United States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Bagher Seyedalipour, <email>b.seyedalipour@umz.ac.ir</email>, <email>b.alipour81@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>02</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1532375</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>11</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>01</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Hosseini Faradonbeh, Seyedalipour, Keivan Behjou, Rezaei, Baziyar and Hosseinkhani.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Hosseini Faradonbeh, Seyedalipour, Keivan Behjou, Rezaei, Baziyar and Hosseinkhani</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Protein stability is a crucial characteristic that influences both protein activity and structure and plays a significant role in several diseases. Cu/Zn superoxide dismutase 1 (SOD1) mutations serve as a model for elucidating the destabilizing effects on protein folding and misfolding linked to the lethal neurological disease, amyotrophic lateral sclerosis (ALS). In the present study, we have examined the structure and dynamics of the SOD1 protein upon two ALS-associated point mutations at the surface (namely, E49K and R115G), which are located in metal-binding loop IV and Greek key loop VI, respectively. Our analysis was performed through multiple algorithms on the structural characterization of the hSOD1 protein using computational predictions, molecular dynamics (MD) simulations, and experimental studies to understand the effects of amino acid substitutions. Predictive results of computational analysis predicted the deleterious and destabilizing effect of mutants on hSOD1 function and stability. MD outcomes also indicate that the mutations result in structural destabilization by affecting the increased content of &#x3b2;-sheet structures and loss of hydrogen bonds. Moreover, comparative intrinsic and extrinsic fluorescence results of WT-hSOD1 and mutants indicated structural alterations and increased hydrophobic surface pockets, respectively. As well, the existence of &#x3b2;-sheet-dominated structures was observed under amyloidogenic conditions using FTIR spectroscopy. Overall, our findings suggest that mutations in the metal-binding loop IV and Greek key loop VI lead to significant structural and conformational changes that could affect the structure and stability of the hSOD1 molecule, resulting in the formation of toxic intermediate species that cause ALS.</p>
</abstract>
<kwd-group>
<kwd>protein structure</kwd>
<kwd>protein stability</kwd>
<kwd>human superoxide dismutase-1</kwd>
<kwd>E49K</kwd>
<kwd>R115G</kwd>
<kwd>protein aggregation</kwd>
<kwd>ALS</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Molecular Biophysics</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>The stability of a protein is a vital feature that affects protein activity, structure, and regulation. It plays an essential role in evolution, industrial applications, and many diseases (<xref ref-type="bibr" rid="B26">Chen et al., 2020</xref>). Protein folding and stability are maintained by interactions among inner and outer residues. The hydrophobic effect, hydrogen bonding, interactions between the tightly packed buried residues, protein electrostatics (<xref ref-type="bibr" rid="B105">Vascon et al., 2020</xref>), and flexibility contribute to the stability of a protein (<xref ref-type="bibr" rid="B50">Kamerzell and Middaugh, 2008</xref>; <xref ref-type="bibr" rid="B96">Teilum et al., 2011</xref>). Studying the biophysical and biochemical principles behind protein stability through theoretical and experimental approaches has become an increasing interest over the past several decades (<xref ref-type="bibr" rid="B56">Kumar et al., 2017</xref>; <xref ref-type="bibr" rid="B48">Jahan and Nayeem, 2020</xref>; <xref ref-type="bibr" rid="B74">Pereira et al., 2021</xref>). Human superoxide dismutase 1 (hSOD1) is an incredibly stable metalloenzyme and has become a paradigm for investigating the destabilizing effect on protein folding and misfolding linked to the fatal neurodegenerative disease, amyotrophic lateral sclerosis (ALS) (<xref ref-type="bibr" rid="B103">Valentine et al., 2005</xref>; <xref ref-type="bibr" rid="B81">Rakhit and Chakrabartty, 2006</xref>). ALS is known as Lou Gehrig&#x2019;s and motor neuron disease that causes progressive, lethal, degenerative disorder of motor neurons, and the disease kills its victim typically 3&#x2013;5 years after initial diagnosis (<xref ref-type="bibr" rid="B95">Taylor et al., 2016</xref>). About 20% of FALS patients are linked to mutations in the SOD1 gene (<xref ref-type="bibr" rid="B84">Rosen et al., 1993</xref>). Mature and functional SOD1 is a 32 kDa homodimeric protein with 153 amino acid residues in each subunit that catalyzes the conversion of the toxic superoxide anion to hydrogen peroxide and molecular oxygen. Each monomer is composed of an eight-stranded antiparallel &#x3b2;-barrel connected by three external loops (<xref ref-type="bibr" rid="B93">Strange et al., 2003</xref>). Furthermore, each monomeric subunit has two metal-binding sites, one for copper and one for zinc, and an intramolecular disulfide bond ranging from Cys57 to Cys146 stabilizes them (<xref ref-type="bibr" rid="B15">Baziyar et al., 2022</xref>). The two active site loops are metal-binding loop IV (residues 49&#x2013;82) and electrostatic loop VII (residues 121&#x2013;142). Loop IV is divided into three subregions: the dimer interface region (residues 49&#x2013;54), the disulfide bond region (residues 55&#x2013;61), and the zinc-binding region (residues 62&#x2013;82) (<xref ref-type="bibr" rid="B44">Hwang et al., 2010</xref>). Finally, a third and shorter loop, referred to as the Greek key loop VI (residues 102&#x2013;115), forms a plug at one pole of the &#x3b2;-barrel and enhances dimer interface stability (<xref ref-type="bibr" rid="B102">Trist et al., 2021</xref>). Several residues, including V5, V7, K9, I17, E49-T54, I113-R115, and V148-Q153, are involved in the intra-subunit interactions at the dimer interface of SOD1 (<xref ref-type="bibr" rid="B35">Ghosh et al., 2020</xref>). Some novel mutations related to FALS were identified by Boukaftan et al. in exon 2 of the hSOD1 gene. A new mutation causes glutamic acid, a negatively charged amino acid, to be replaced by lysine, a positively charged amino acid (E49K), while the amino acid Glu 49 is not generally conserved across species (<xref ref-type="bibr" rid="B18">Boukaftane et al., 1998</xref>). Kostrzewa et al. reported a new mutation in exon 4 of the hSOD1 gene, which causes arginine to be replaced by glycine (R115G). This substitution constitutes a significant amino acid change from a positively charged (Arg) to a neutral (Gly) amino acid, while amino acid Arginine 115 is highly conserved in different species, which indicates an important function of Arg at this position of the enzyme. The location of Arg 115 in the dimer contact site of the SOD1 protein suggests its relevance to the structural integrity of the enzyme (<xref ref-type="bibr" rid="B53">Kostrzewa et al., 1994</xref>). Up to now, more than 200 mutations have been reported in FALS patients (<ext-link ext-link-type="uri" xlink:href="http://alsod.iop.kcl.ac.uk/">http://alsod.iop.kcl.ac.uk/</ext-link>) (<xref ref-type="bibr" rid="B3">Abel et al., 2012</xref>; <xref ref-type="bibr" rid="B14">Basith et al., 2022</xref>; <xref ref-type="bibr" rid="B94">Suzuki et al., 2023</xref>). In the last few years, significant efforts have been implicated to reveal the effects of ALS-associated mutations on the biochemical and biophysical properties of hSOD1 (<xref ref-type="bibr" rid="B68">Namadyan et al., 2023</xref>; <xref ref-type="bibr" rid="B112">Zaji et al., 2023</xref>). Remarkably, the location of these mutations is all over the SOD1 structure, which makes it challenging to determine the exact destabilizing process (<xref ref-type="bibr" rid="B100">Tompa et al., 2020</xref>). These mutations lead to reduced metal ion content, decreased net charge (in some cases), disruption of the surface hydrogen bond network, increase in the hydrophobicity, changes in the flexibility, and alternations in the functional characteristics of SOD1, therefore play a crucial role in the formation of toxic aggregates and the pathology of ALS (<xref ref-type="bibr" rid="B10">Antonyuk et al., 2005</xref>; <xref ref-type="bibr" rid="B52">Khare and Dokholyan, 2006</xref>; <xref ref-type="bibr" rid="B21">Bystr&#xf6;m et al., 2010</xref>; <xref ref-type="bibr" rid="B99">Tompa and Kadhirvel, 2020</xref>; <xref ref-type="bibr" rid="B61">Mavadat et al., 2023a</xref>; <xref ref-type="bibr" rid="B62">Mavadat et al., 2023b</xref>). Against this background, the current study was an attempt to shed light on the structural and dynamical features of the holo forms of the wild-type hSOD1 (WT-hSOD1) (<xref ref-type="fig" rid="F1">Figure 1</xref>), E49K, and R115G mutants in metal-binding loop IV and Greek key loop VI, respectively, using computational predictions, molecular dynamics (MD) simulations, and experimental studies to characterize some physicochemical properties and their relation to enzymatic activity, stability, and protein aggregation on an atomic and a molecular level.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Structure of dimeric human SOD1 in non-pathogen conformation (PDB ID: 2C9V). Chain F is depicted in surface representation for clarity, and in chain A, E49 and R115 residues are shown green and red, respectively. The metal-binding loop IV (residues 49&#x2013;82) and the Greek key loop VI (residues 102&#x2013;115) are functionally significant structural elements of the SOD1 structure, represented in yellow and purple, respectively. The Cu and Zn ions are shown as brown and blue spheres, respectively. The graphic was generated using UCSF Chimera software.</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g001.tif"/>
</fig>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>2 Materials and methods</title>
<sec id="s2-1">
<title>2.1 Computational methods</title>
<sec id="s2-1-1">
<title>2.1.1 Sequence analysis and dataset</title>
<p>The amino acid sequence of hSOD1 was achieved from the UniProt database (ID: P00441) (<xref ref-type="bibr" rid="B28">Consortium, 2015</xref>). The structure for the WT-SOD1 protein was acquired through the Protein Data Bank [PDB ID: 2C9V] (<xref ref-type="bibr" rid="B17">Berman et al., 2000</xref>). The PDB ID: 2C9V structure was employed because it has the highest atomic resolution (1.07&#xc5;) compared to other SOD1 structures (<xref ref-type="bibr" rid="B74">Pereira et al., 2021</xref>).</p>
</sec>
<sec id="s2-1-2">
<title>2.1.2 Functional and stability prediction analysis</title>
<p>The functional effects of E49K and R115G mutants on hSOD1 protein were predicted using the following algorithms: Panther (<xref ref-type="bibr" rid="B63">Mi et al., 2005</xref>), PolyPhen-1 (<xref ref-type="bibr" rid="B82">Ramensky et al., 2002</xref>), PolyPhen-2 (<xref ref-type="bibr" rid="B7">Adzhubei et al., 2013</xref>), MAPP (<xref ref-type="bibr" rid="B92">Stone and Sidow, 2005</xref>), Phd Snp (<xref ref-type="bibr" rid="B22">Capriotti et al., 2006</xref>), SIFT (<xref ref-type="bibr" rid="B69">Ng and Henikoff, 2003</xref>), SNAP (<xref ref-type="bibr" rid="B19">Bromberg and Rost, 2007</xref>), and PredictSNP for accurate predictions along with the prediction score. The majority of these tools are designed to predict whether a certain replacement is neutral or deleterious by using a variety of factors obtained from the evolutionary, physicochemical, or structural characteristics (<xref ref-type="bibr" rid="B16">Bendl et al., 2014</xref>). In addition, the effects of mutants on hSOD1 stability were analyzed using the different prediction web servers, viz., DUET (<xref ref-type="bibr" rid="B77">Pires et al., 2014a</xref>), I-Mutant2.0 (<xref ref-type="bibr" rid="B23">Capriotti et al., 2005</xref>), mCSM (<xref ref-type="bibr" rid="B78">Pires et al., 2014b</xref>), DDGun (<xref ref-type="bibr" rid="B66">Montanucci et al., 2019</xref>), SAAFEQ-SEQ (<xref ref-type="bibr" rid="B58">Li et al., 2021</xref>), DynaMut2 (<xref ref-type="bibr" rid="B83">Rodrigues et al., 2021</xref>), and i-Stable. These algorithms evaluated the effect of mutation on hSOD1 stability by using free energy change (&#x394;&#x394;G) calculations, which could report positive and negative values for stabilizing and destabilizing mutations, respectively (<xref ref-type="bibr" rid="B25">Chen et al., 2013</xref>).</p>
</sec>
<sec id="s2-1-3">
<title>2.1.3 Prediction of the effect of mutations on protein structure and conformation</title>
<p>Using Chimera software (<xref ref-type="bibr" rid="B76">Pettersen et al., 2004</xref>) version 1.16 (PDB ID: 2C9V), we have observed changes in the interactions of neighboring amino acids and structural alterations in E49K and R115G mutants compared to WT-hSOD1. The software was used to scan the three-dimensional structure of SOD1 proteins and then replace the native amino acid with the candidate to demonstrate the impact.</p>
</sec>
<sec id="s2-1-4">
<title>2.1.4 Prediction of the effect of mutations on the molecular net charge</title>
<p>The molecular net charge of WT-hSOD1, E49K, and R115G mutants was computed at pH 7.4 using the Prot pi Protein Tool (<ext-link ext-link-type="uri" xlink:href="https://www.protpi.ch/Calculator/ProteinTool">https://www.protpi.ch/Calculator/ProteinTool</ext-link>). In addition, using Chimera software (PDB ID: 2C9V), we have visualized the electrostatic potential map onto the molecular surface of WT-hSOD1 and E49K and R115G mutants.</p>
</sec>
<sec id="s2-1-5">
<title>2.1.5 Molecular dynamics simulations</title>
<p>Molecular Dynamics (MD) simulations of the WT-hSOD1 protein and its mutants (E49K and R115G) were performed using the GROMACS 2022.6 software package (<xref ref-type="bibr" rid="B104">Van Der Spoel et al., 2005</xref>). The program Visual Molecular Dynamics 1.9.3 was utilized to induce the mutations (E49K and R115G) on the crystallographic structure of the WT-hSOD1 dimer (PDB ID: 2C9V). The force field CHARMM36-JUL2022 was selected for the simulations. The molecules were solvated in a triclinic box with TIP3P water molecules, and to maintain overall charge neutrality, sodium (Na&#x207a;) and chloride (Cl&#x207b;) ions were introduced to substitute some solvent molecules. The simulations were performed in four distinct stages. In the initial stage, the energy in the system was minimized using the steepest descent algorithm to eliminate additional forces acting on the atoms, thereby relaxing the systems. The subsequent second and third stages maintained a temperature of 300 K and a pressure of 1 bar, achieved through two 1-nanosecond (ns) simulations conducted in the canonical (NVT) and isothermal-isobaric (NPT) ensembles, with position restraints applied to the heavy atoms. The final phase removed position restraints on all atoms and included a 300 ns simulation with a time step of 2 femtoseconds (fs), allowing for trajectory recording to extract various physical properties. Copper (Cu) and zinc (Zn) ions were restrained to their designated binding sites throughout the simulations. Subsequently, the MD trajectories were analyzed using the following GROMACS package distribution programs: gmx rms, gmx hbond, gmx gyrate, gmx sasa, gmx rmsf, and gmx dssp to compute root-mean-square deviation (RMSD), hydrogen bonds (H-bond), radius of gyration (Rg), solvent-accessible surface area (SASA), root-mean-square fluctuation (RMSF), and secondary structure (SS), respectively. PCA is referred to as essential dynamics (ED) when used for the analysis of molecular dynamics (MD) simulations (<xref ref-type="bibr" rid="B73">Pereira et al., 2020</xref>). Theoretical aspects of PCA have been thoroughly discussed in prior studies (<xref ref-type="bibr" rid="B112">Zaji et al., 2023</xref>). The GROMACS tools performed PCA of the WT-SOD1, E49K, and R115G mutants in each system. Additionally, the popular conformations were examined utilizing the clustering scheme of GROMACS with a cutoff of 0.2 nm.</p>
</sec>
<sec id="s2-1-6">
<title>2.1.6 Free energy landscape</title>
<p>The free energy landscape of a protein was obtained using the conformational sampling approach, which produces the near-native structural conformation. The free energy landscape (FEL) for conformational sampling of the WT-SOD1, E49K, and R115G mutants was constructed using simulated trajectory data. Consequently, FEL was derived by mixing RMSD and Rg trajectories with free energy according to the following <xref ref-type="disp-formula" rid="e1">Equation 1</xref>:<disp-formula id="e1">
<mml:math id="m1">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>p</mml:mi>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#x2212;</mml:mo>
<mml:msub>
<mml:mi>k</mml:mi>
<mml:mi mathvariant="normal">B</mml:mi>
</mml:msub>
<mml:mi>T</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mi>ln</mml:mi>
<mml:mo>&#x2061;</mml:mo>
<mml:mi>&#x3c1;</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>p</mml:mi>
<mml:mn>1</mml:mn>
<mml:mo>,</mml:mo>
<mml:mi>p</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>Where in, &#x394;G depicts the Gibbs free energy of state, <italic>k</italic>
<sub>B</sub> represents the Boltzmann constant and <italic>T</italic> corresponds to the temperature of the simulation. The FEL&#x2019;s reaction coordinates <italic>p</italic>1 and <italic>p</italic>2, are shown by joint probability distribution <italic>&#x3c1;</italic> (<italic>p</italic>1, <italic>p</italic>2) (<xref ref-type="bibr" rid="B72">Papaleo et al., 2009</xref>; <xref ref-type="bibr" rid="B70">Noorbakhsh Varnosfaderani et al., 2023</xref>).</p>
</sec>
<sec id="s2-1-7">
<title>2.1.7 Binding free energy and per-residue free energy decomposition analysis</title>
<p>The g_mmpbsa tool was employed to calculate the binding free energy of the WT-hSOD1 and its mutants (E49K and R115G). g_mmpbsa computed the binding free energy of the complex structure using the Molecular Mechanics Poisson&#x2013;Boltzmann Surface Area (MM/PBSA) methodology (<xref ref-type="bibr" rid="B14">Basith et al., 2022</xref>). The following <xref ref-type="disp-formula" rid="e2">Equation 2</xref> is used to determine the binding free energy &#x394;G<sub>binding</sub> of a complex:<disp-formula id="e2">
<mml:math id="m2">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mtext>binding</mml:mtext>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#x394;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mtext>complex</mml:mtext>
</mml:msub>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mo>&#x2013;</mml:mo>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mrow>
<mml:mtext>protein</mml:mtext>
<mml:mn>1</mml:mn>
</mml:mrow>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:mo>&#x394;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mrow>
<mml:mtext>protein</mml:mtext>
<mml:mn>2</mml:mn>
</mml:mrow>
</mml:msub>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>
</p>
<p>Here, &#x394;<sub>Gcomplex</sub> demonstrates the total MMPBSA energy of the protein-protein complex; &#x394;G<sub>protein1</sub> and &#x394;G<sub>protein2</sub> are solution-free energies of the individual protein<sub>1</sub> and protein<sub>2</sub>, respectively. The free energy of the individual existence can be expressed as follows <xref ref-type="disp-formula" rid="e3">Equation 3</xref>:<disp-formula id="e3">
<mml:math id="m3">
<mml:mrow>
<mml:mo>&#x394;</mml:mo>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">E</mml:mi>
<mml:mtext>MM</mml:mtext>
</mml:msub>
<mml:mo>&#x2b;</mml:mo>
<mml:msub>
<mml:mi mathvariant="normal">G</mml:mi>
<mml:mtext>solvation</mml:mtext>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:mtext>TS</mml:mtext>
</mml:mrow>
</mml:math>
<label>(3)</label>
</disp-formula>
</p>
<p>E<sub>MM</sub> shows the average molecular mechanical potential energy in the vacuum; G<sub>solvation</sub> defines the free energy of solvation. T and S explain the temperature and entropy, respectively, and together TS exhibits the entropic contribution to the free energy in vacuum. In addition, the E<sub>MM</sub> contains both bonded and nonbonded interactions of the molecules, including the bond angle, torsion, and electrostatic (E<sub>elec</sub>) and van der Waals (E<sub>vdw</sub>) interactions. Last, the free energy of solvation and G<sub>solvation</sub> include both electrostatic and nonelectrostatic (G<sub>polar</sub> and G<sub>nonpolar</sub>) components (<xref ref-type="bibr" rid="B57">Kumari et al., 2014</xref>). To gain more insights into the residue contributions, the residues of SOD1 responsible for the interface surface were computed using the MM-PBSA per residue free energy decomposition method (mm_pbsa module) of GROMACS-CHARMM36. These calculations were based on the same snapshots as those used in the binding free energy calculations.</p>
</sec>
</sec>
<sec id="s2-2">
<title>2.2 Experimental methods</title>
<sec id="s2-2-1">
<title>2.2.1 Materials</title>
<p>A plasmid extraction kit was purchased from GeneAll (South Korea). <italic>Pfu</italic> polymerase and Ni-NTA agarose resin were obtained from Agarose Bead Technologies (ABT) and Wizbiosolutions, respectively. <italic>Dpn I</italic> was purchased from Thermo Scientific. Phenylmethylsulfonyl fluoride (PMSF), Kanamycin, Dialysis tubing cellulose membrane (12,400 Da cutoff), 1-Anilinonaphthalene-8-sulfonate (ANS), and Isopropyl-D-thiogalactopyranoside (IPTG) were acquired from Sigma. Dithiothreitol (DTT), Yeast Extract, Tryptone, and Agarose were obtained from Bio Basic. Copper sulfate (CuSO<sub>4</sub>) and zinc sulfate (ZnSO<sub>4</sub>) were purchased from Merck. All other reagents were of analytical reagent grade and were used without further purification.</p>
</sec>
<sec id="s2-2-2">
<title>2.2.2 Site-directed mutagenesis and WT-hSOD1 and mutant expression and purification</title>
<p>The recombinant pET28a-hSOD1 served as the template to create E49K and R115G mutations using <italic>Pfu</italic> DNA polymerase and the QuickChange site-directed mutagenesis method. Two mutagenesis primers for E49K were designed: forward primer (5&#x2032;TGGATTCCATGTTCAT<bold>AAG</bold>TTTGGAGATA ATACAGCAG-3&#x2032;) with mutation site (highlighted) and reverse primer (5&#x2032;-AGCCTGCTGTATTAT CTCCAAA<bold>CTT</bold>ATGAACATGG-3&#x2032;) with mutation site (highlighted). Additionally, two primers were designed for the R115G mutation: the forward primer (5&#x2032;-ACCATTGCATCATTGGC<bold>GGC</bold>A CACTGGTGG-3&#x2032;) with mutation site (highlighted) and the reverse primer (5&#x2032;-TCATGGACCACCA GTGT<bold>GCC</bold>GCCAATGATGC-3&#x2032;) with mutation site (highlighted) were designed to amplify pET28a-hSOD1 as a template. The product PCR is digested with <italic>Dpn I</italic> to destroy methylated parental plasmid DNA. The recombinant expression plasmid was transformed into <italic>E. coli</italic> BL21 (DE3) competent cells for protein production by heat shock. The protein was expressed, purified using a Ni-NTA affinity column, and characterized. The purified SOD1 proteins were reconstituted with CuSO<sub>4</sub> and ZnSO<sub>4</sub> by dialysis in 3 main steps: metal removal, metal charging, and removal of unbound metals at 4&#xb0;C, as previously described (<xref ref-type="bibr" rid="B65">Mohammadi et al., 2024</xref>). The concentration of purified WT-hSOD1, E49K, and R115G mutant proteins was determined by the Bradford method. Using a 12.5% SDS-PAGE electrophoresis, a single band of about 16 kDa was observed with high purity (data not shown).</p>
</sec>
<sec id="s2-2-3">
<title>2.2.3 Enzymatic activity assay of WT-hSOD1, E49K and R115G mutants</title>
<p>Enzyme activity assay was performed in a volume of 300 &#x3bc;L composed of Tris-HCl buffer (50 mM) containing EDTA (1 mM; pH 8.2), 0.1 mM pyrogallol (dissolved in 10 mM HCl), and 20 &#x3bc;L of enzyme purified by the Marklund method (<xref ref-type="bibr" rid="B60">Marklund and Marklund, 1974</xref>) in a microplate spectrophotometer reader (Epoch, BioTek, USA). The rate of pyrogallol autoxidation depends on the availability of superoxide and is monitored spectrophotometrically (at 420 nm, 5 min, 30 s intervals) by a color change. One unit of SOD1 activity is defined as the enzyme amount inhibiting pyrogallol autoxidation by 50% per minute, with specific activity measured in U/mg protein (<xref ref-type="bibr" rid="B98">Tiwari et al., 2019</xref>).</p>
</sec>
<sec id="s2-2-4">
<title>2.2.4 Spectroscopic characterization</title>
<p>Intrinsic (Trp) fluorescence in proteins is a widely used tool for monitoring protein changes, providing detailed information on dynamics and conformational changes (<xref ref-type="bibr" rid="B106">Vivian and Callis, 2001</xref>; <xref ref-type="bibr" rid="B34">Ghisaidoobe and Chung, 2014</xref>). Intrinsic fluorescence measurements were carried out using a spectrofluorometer JASCO fluorescence spectrophotometer (FP-8300) with excitation fixed at 295 nm, and emission spectra were measured between 300 and 500 nm (Exc/Em slit widths &#x3d; 5/10 nm, respectively). Extrinsic fluorescence studies using ANS are applied to monitor exposed hydrophobic pockets (<xref ref-type="bibr" rid="B40">Hawe et al., 2008</xref>). ANS fluorescence emission spectra were measured from 400 to 700 nm, with excited at 370 nm. The purified enzyme concentration was 20 &#x3bc;g/mL for each assay in phosphate buffer (20 mM, pH 7.4). Additionally, intrinsic fluorescence and extrinsic fluorescence emission spectra were investigated under amyloidogenic conditions (DTT 50 mM, Tris-HCl 50 mM, and KSCN 0.16 M). The concentration of ANS was 30 &#x3bc;M with a protein-to-ANS ratio of 1:30.</p>
</sec>
<sec id="s2-2-5">
<title>2.2.5 Fourier-transform infrared spectroscopy</title>
<p>Using potassium bromide (KBr) tablets, FTIR spectroscopy (BRUKER TENSOR 27, Germany) was used to examine the protein&#x2019;s secondary structure of the WT-SOD1, E49K, and R115G mutants. The infrared spectra were recorded at a resolution of 4 cm<sup>&#x2212;1</sup>, spanning the range of 400&#x2013;4,000 cm<sup>&#x2212;1</sup>. The protein samples were investigated under amyloidogenic conditions (50 mM Tris-HCl, 50 mM DTT, 0.16 M KSCN) at a concentration of 25 &#x3bc;M. Subsequently, 10 &#x3bc;L of each sample was used for FTIR evaluations. The buffer baseline was then subtracted before taking each spectrum (<xref ref-type="bibr" rid="B27">Chowdhury et al., 2019</xref>). The peak assignments were accordingly made by the previously described spectral components associated with various secondary structure elements (<xref ref-type="bibr" rid="B38">Gregoire et al., 2012</xref>). The raw spectra in the amide I region (1,600&#x2013;1,700 cm<sup>&#x2212;1</sup>) were further processed, using the OriginPro 2021 software package. In the FTIR curve fitting method for analyzing the amide I band components, Fourier self-dissociation (FSD) and second derivative spectra were used to elucidate the overlapping peaks in the amide I region.</p>
</sec>
<sec id="s2-2-6">
<title>2.2.6 Characterization of hSOD1 aggregation by ThT fluorescence</title>
<p>The fibrillation kinetics was investigated by thioflavin-T (ThT) fluorescence assay based on the rise in the fluorescence quantum efficiency of ThT after binding to the amyloid fibers. The aggregated SOD1 protein samples, under the conditions inducing amyloid aggregate formation (viz., 0.16 M KSCN, 50 mM DTT, 50 mM Tris-HCl) at 37&#xb0;C (pH 7.4) and 190 rpm were then incubated. The concentration of the SOD1 variants fibrils (30 &#x3bc;M dimer, 20 mM phosphate buffer, pH 7.4) was also obtained. ThT (20 &#x3bc;M) was then added to the incubated samples at different time intervals. Afterward, fluorescence was recorded with the excitation and emission at 444 nm and 485 nm, respectively. The excitation and emission slit widths were subsequently set at 5 and 10 nm, in that order. The reported data were thus the mean measurements in three replicates. As previously reported (<xref ref-type="bibr" rid="B32">Esmaeili et al., 2020</xref>), the fibrillation kinetic parameters were acquired using the following <xref ref-type="disp-formula" rid="e4">Equation 4</xref>:<disp-formula id="e4">
<mml:math id="m4">
<mml:mrow>
<mml:mi mathvariant="normal">F</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>F</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>x</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mn>1</mml:mn>
<mml:mo>&#x2b;</mml:mo>
<mml:mi>exp</mml:mi>
<mml:mrow>
<mml:mfenced open="{" close="" separators="|">
<mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mrow>
<mml:mfenced open="[" close="]" separators="|">
<mml:mrow>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>t</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>t</mml:mi>
<mml:mi>m</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>/</mml:mo>
<mml:mi>&#x3c4;</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(4)</label>
</disp-formula>where <italic>F</italic> and <italic>F</italic>
<sub>max</sub> represent the fluorescence intensity at time <italic>t</italic> and the end time of ThT signal recording, respectively. As well, <italic>t</italic> shows the characteristic time constant and <italic>t</italic>
<sub>
<italic>m</italic>
</sub> stands for the time through which the half of the amyloid aggregates are formed. <italic>F</italic>
<sub>max</sub> and <italic>&#x3c4;</italic> are the floating parameters, according to the Best-Fit (BF) method. Furthermore, <italic>k</italic>
<sub>
<italic>app</italic>
</sub> denotes the apparent rate constant, given by 1/<italic>&#x3c4;</italic> for the increase in the length of fibrils, and the formula of <italic>t</italic>
<sub>
<italic>D</italic>
</sub> &#x3d; <italic>t</italic>
<sub>
<italic>m</italic>
</sub> - 2<italic>&#x3c4;</italic> is then practiced to calculate the delay time (<italic>t</italic>
<sub>
<italic>D</italic>
</sub>).</p>
</sec>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>3 Results and discussion</title>
<sec id="s3-1">
<title>3.1 Computational section</title>
<sec id="s3-1-1">
<title>3.1.1 Functional and stability prediction analysis</title>
<p>The analysis of single nucleotide variations and their prioritization for experimental characterization heavily relies on computational methods to predict the effects of mutations on protein function (<xref ref-type="bibr" rid="B16">Bendl et al., 2014</xref>). The effect of mutations on the hSOD1 protein function was analyzed by eight algorithms: PANTHER, SIFT, SNAP, PhD-SNP, MAPP, PolyPhen-1, PolyPhen-2, and Predict-SNP were combined into a consensus classifier, PredictSNP. The results from all those tools predicted that the mutations are deleterious except Polyphen-2 for the E49K mutant, indicating the neutral effect of the mutation on hSOD1 function with a confidence score of 0.68. Using Predict-SNP, the confidence score predicted for E49K and R115G mutants was found to be 0.72 and 0.87, respectively, which suggested that the mutations have a deleterious effect on hSOD1 protein function. The confidence score that was calculated from each tool was tabulated in <xref ref-type="table" rid="T1">Table 1</xref>. These results demonstrate the importance of using different algorithms to ensure optimal reliability. Protein stability is crucial in thermodynamics, determined by the change in free energy between the folded and unfolded states (<xref ref-type="bibr" rid="B90">Srinivasan and Rajasekaran, 2018</xref>). The stability hSOD1 concerning mutations was examined through &#x394;&#x394;G calculations using several predictive tools available on the web, including i-Stable, I-mutant2.0, DUET, mCSM, DDGun, DynaMut2, and SAAFEC-SEQ. The results of integrated servers computed in this line for E49K and R115G mutations as presented in <xref ref-type="table" rid="T2">Table 2</xref> showed destabilizing effects of mutation on the hSOD1 structure. Previous reports have established the role of some mutations on the function and stability of SOD1 using various computational tools (<xref ref-type="bibr" rid="B89">Srinivasan and Rajasekaran, 2017</xref>; <xref ref-type="bibr" rid="B90">2018</xref>; <xref ref-type="bibr" rid="B29">Da Silva et al., 2019</xref>; <xref ref-type="bibr" rid="B91">Srinivasan and Rajasekaran, 2019</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Functional predictions and confidence scores for the hSOD1 mutants (E49K and R115G) were computed from the top eight algorithms of the PREDICT-SNP server.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Programs</th>
<th align="center">E49K&#x2a;</th>
<th align="center">R115G&#x2a;&#x2a;</th>
<th rowspan="2" align="center">Prediction</th>
</tr>
<tr>
<th colspan="2" align="center">Confidence score</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Predict SNP</td>
<td align="center">0.72</td>
<td align="center">0.87</td>
<td align="center">Deleterious</td>
</tr>
<tr>
<td align="center">MAPP</td>
<td align="center">0.43</td>
<td align="center">0.62</td>
<td align="center">Deleterious</td>
</tr>
<tr>
<td align="center">Phd-SNP</td>
<td align="center">0.88</td>
<td align="center">0.88</td>
<td align="center">Deleterious</td>
</tr>
<tr>
<td align="center">PolyPhen-1</td>
<td align="center">0.59</td>
<td align="center">0.59</td>
<td align="center">Deleterious</td>
</tr>
<tr>
<td align="center">Polyphen-2</td>
<td align="center">0.68</td>
<td align="center">0.81</td>
<td align="center">Neutral&#x2a;/Deleterious&#x2a;&#x2a;</td>
</tr>
<tr>
<td align="center">SIFT</td>
<td align="center">0.53</td>
<td align="center">0.53</td>
<td align="center">Deleterious</td>
</tr>
<tr>
<td align="center">SNAP</td>
<td align="center">0.72</td>
<td align="center">0.81</td>
<td align="center">Deleterious</td>
</tr>
<tr>
<td align="center">PANTHER</td>
<td align="center">0.69</td>
<td align="center">0.84</td>
<td align="center">Deleterious</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Note: The SNP, prediction was performed at pH &#x3d; 7.4&#xb0;C and 25&#xb0;C. Abbreviations: SNP, single-nucleotide polymorphism.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Stability prediction results using <italic>in silico</italic> analysis of hSOD1 mutants (E49K and R115G).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Programs</th>
<th align="center">E49K</th>
<th align="center">R115G</th>
<th rowspan="2" align="center">Results</th>
</tr>
<tr>
<th colspan="2" align="center">&#x2206;&#x2206;<italic>G</italic> (Kcal/mol)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">i-Stable</td>
<td align="center">&#x2212;0.244</td>
<td align="center">&#x2212;0.164</td>
<td align="center">Decreases</td>
</tr>
<tr>
<td align="center">AUTO&#x2013;MUTE SVM</td>
<td align="center">&#x2212;1.15</td>
<td align="center">&#x2212;1.25</td>
<td align="center">Decreases</td>
</tr>
<tr>
<td align="center">AUTO&#x2013;MUTE RF</td>
<td align="center">&#x2212;1.85</td>
<td align="center">&#x2212;0.22</td>
<td align="center">Decreases</td>
</tr>
<tr>
<td align="center">I-mutant2.0 PDB</td>
<td align="center">&#x2212;0.96</td>
<td align="center">&#x2212;1.60</td>
<td align="center">Decreases</td>
</tr>
<tr>
<td align="center">I-mutant2.0 SEQ</td>
<td align="center">&#x2212;0.54</td>
<td align="center">&#x2212;0.89</td>
<td align="center">Decreases</td>
</tr>
<tr>
<td align="center">DUET</td>
<td align="center">&#x2212;1.04</td>
<td align="center">&#x2212;2.133</td>
<td align="center">Destabilizing</td>
</tr>
<tr>
<td align="center">mCSM</td>
<td align="center">&#x2212;1.268</td>
<td align="center">&#x2212;2.401</td>
<td align="center">Destabilizing</td>
</tr>
<tr>
<td align="center">DDGun</td>
<td align="center">&#x2212;1</td>
<td align="center">&#x2212;2.7</td>
<td align="center">Destabilizing</td>
</tr>
<tr>
<td align="center">DDGun3D</td>
<td align="center">&#x2212;0.5</td>
<td align="center">&#x2212;2.1</td>
<td align="center">Destabilizing</td>
</tr>
<tr>
<td align="center">DynaMut2</td>
<td align="center">&#x2212;0.96</td>
<td align="center">&#x2212;2.78</td>
<td align="center">Destabilizing</td>
</tr>
<tr>
<td align="center">SAAFEC-SEQ</td>
<td align="center">&#x2212;0.38</td>
<td align="center">&#x2212;0.64</td>
<td align="center">Destabilizing</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Note: In silico analysis for stability, prediction was performed at pH &#x3d; 7.4&#xb0;C and 25&#xb0;C.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-1-2">
<title>3.1.2 Molecular modeling</title>
<p>To elucidate the effects of amino acid substitutions, we utilized the UCSF Chimera software for evaluating the impacts of single-point mutations on conformational alterations of the E49K and R115G mutants compared to WT-hSOD1 (<xref ref-type="fig" rid="F2">Figure 2A</xref>), thereby enhancing our understanding of their contribution to disease development. As shown in <xref ref-type="fig" rid="F2">Figure 2B1</xref>, the glutamic acid residue at position 49 (E49) is vital for enabling significant interactions inside protein structures by forming hydrogen bonds and van der Waals interactions. Before the E49K mutation, E49 establishes significant hydrogen bonds with the residues Arg115 and Pro62. These hydrogen bonds promote the three-dimensional structure of the protein to be stabilized and enable important chemical interactions required for appropriate biological function. Apart from its hydrogen bonding features, E49 interacts by van der Waals with Pro62. This connection increases the stability of the protein structure by supporting the integrity of the protein&#x2019;s core and enhancing the hydrophobic environment. Substituting Lys with Glu at position 49 destabilizes the surrounding area. The absence of van der Waals interaction with Pro62 may modify the spatial arrangement of this residue inside the protein, despite the hydrogen bonds between Arg115 and Pro62 being intact, the alteration in the spatial arrangement of this residue may affect the protein&#x2019;s overall stability and functionality (<xref ref-type="fig" rid="F2">Figure 2B2</xref>). As illustrated in <xref ref-type="fig" rid="F2">Figure 2C1</xref>, the original residue R115 is crucial for the structural stability and functional interaction of proteins since its various bonds can endow the protein&#x2019;s integrity. The ability of R115 to form hydrogen bonds with key residues (Glu49, Cys111, Ilu112, Ilu149) of the protein is conspicuous. Besides hydrogen bonding, R115 establishes van der Waals interactions with Phe64 and His48, along with hydrophobic interaction with Val47. Moreover, Arg115 forms a van der Waals interaction with Ilu151 in chain F. These types of interactions contribute significantly to the overall stability of the protein structure. The R115G mutation significantly alters the hydrogen bonding networks and interaction profiles by substituting R115 with G. After this mutation, the hydrogen bonds that were engaged in Glu49 and Cys111 are eliminated, resulting in the local structure of the protein being disturbed. Specifically, Glu49 located in the E49-T54 loop region is crucial for the robust binding of monomers at the dimer interface; any abnormal fluctuations in this loop region might adversely affect the stability of the SOD1 dimer (<xref ref-type="bibr" rid="B35">Ghosh et al., 2020</xref>). Notably, Cys111, located on the surface adjacent to the dimer interface of the SOD1 subunit, is oxidized by redox substrates in human wild-type SOD1. These oxidative changes of Cys111 may alter the structure of the SOD1 dimer, leading to monomerization and subsequent aggregation formation of the SOD1 protein (<xref ref-type="bibr" rid="B67">Nagano et al., 2015</xref>). Furthermore, the R115G mutation reduces the van der Waals interactions with Phe64, His48, and Ilu151 (chain F) and the hydrophobic contact with Val47, which were formerly sustained by R115. In addition to disrupting these crucial connections that enhance the protein&#x2019;s dimer stability, the absence of R115 may also reveal hydrophobic pockets typically buried within the protein&#x2019;s core (<xref ref-type="fig" rid="F2">Figure 2C2</xref>). This exposure may result in increased aggregation tendency.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> A general schematic of WT-hSOD1 and the location of the investigated mutations (E49K and R115G) (PDB ID: 2C9V). <bold>(B1)</bold> Schematic illustrations of the interaction between the Glu49 side chain in WT-hSOD1 and <bold>(B2)</bold> Lys49 side-chain mutant protein (E49K) with the neighboring residues. <bold>(C1)</bold> Schematic demonstrations of the interaction between the Arg115 side chain in WT-hSOD1 and <bold>(C2)</bold> Gly115 side-chain mutant protein (R115G) with the neighboring residues. Hydrogen bonds (distance in &#xc5;) are illustrated as a solid line, while close contacts and clashes among residues are represented by a dashed line. The graphic was generated using UCSF Chimera software.</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g002.tif"/>
</fig>
</sec>
<sec id="s3-1-3">
<title>3.1.3 Molecular net charge analysis</title>
<p>The charged and polar side chains of SOD1, similar to other soluble proteins, are located on the protein surface, protrude freely into the solvent, or participate in solvent-accessible salt bridges and hydrogen bonding (<xref ref-type="bibr" rid="B21">Bystr&#xf6;m et al., 2010</xref>). The active site is positively charged and accounts for around 11% of the exposed surface, whereas the remainder is negatively charged (<xref ref-type="bibr" rid="B81">Rakhit and Chakrabartty, 2006</xref>). A protein&#x2019;s net charge is a key physical characteristic that affects its solubility and aggregation (<xref ref-type="bibr" rid="B36">Gitlin et al., 2006</xref>). Biomolecules often possess a net negative charge to ensure solubility inside the cellular interior. Each SOD1 monomer normally has a net charge of &#x2212;6 (<xref ref-type="bibr" rid="B88">Sandelin et al., 2007</xref>). Point mutations in SOD1 that cause ALS often reduce the net negative of SOD1 (<xref ref-type="bibr" rid="B79">Prudencio et al., 2009</xref>). At pH 7.4 using the Prot pi Protein Tool, the WT-hSOD1, E49K, and R115G mutants have the molecular net charge (&#x2212;6.52), (&#x2212;4.53), and (&#x2212;7.52), respectively. The results obtained from this tool demonstrated a significant alteration in the molecular net charge of both mutants. Notably, for mutant E49K, there was a reduction in net negative charge compared to the wild-type protein. As illustrated in <xref ref-type="fig" rid="F3">Figure 3</xref>, the electrostatic potential was mapped onto the surfaces of WT-hSOD1. Glu49 is located on the outer surface of metal-binding loop IV, surrounded by positively charged His48 and Arg115, which likely serves to neutralize these positive charges and maintain the surface electrostatic potential of SOD1. Mutation of Glu49 to a positively charged residue (Lys) was found to alter the net negative charge (reduce net negative charge) on the protein&#x2019;s surface (<xref ref-type="fig" rid="F3">Figure 3</xref>), which could reduce the stability of the SOD1 dimer, promote aberrant interactions and misfolding, and/or nucleate aggregation. Arg115 is located on the outer surface of Greek key loop VI, surrounded by negative charge residue (Glu49). On the other hand, an ALS-associated mutation of Arg115 to a neutral residue (Gly) was found to increase the net repulsive charge of the SOD1 (<xref ref-type="fig" rid="F3">Figure 3</xref>). A previous study suggested that two ALS-associated point mutations at the surface residue Glu100 (E100G and E100K) in SOD1, which decrease the net negative charge of the protein by eliminating negatively charged or introducing positively charged amino acids, respectively, could reduce the stability of SOD1 and promote aggregation (<xref ref-type="bibr" rid="B99">Tompa and Kadhirvel, 2020</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Effects of single-point mutations in WT-hSOD1 (PDB ID: 2C9V) on electrostatic potential. Electrostatic potential was mapped onto the surfaces of WT-hSOD1 (Up) vs. E49K (Reduce net negative charge) and R115G (Increase net negative charge) mutants (Down). Electropositively and electronegatively charged areas are colored in blue and red, respectively. Neutral residues are in white. The graphic was generated using UCSF Chimera software.</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g003.tif"/>
</fig>
</sec>
<sec id="s3-1-4">
<title>3.1.4 MD-based simulation analysis</title>
<p>MD simulations capture a diverse range of crucial biomolecular processes that include structural changes and protein folding, alongside forecasting the impacts of mutations on the structure of the protein (<xref ref-type="bibr" rid="B47">Idrees et al., 2017</xref>; <xref ref-type="bibr" rid="B42">Hollingsworth and Dror, 2018</xref>; <xref ref-type="bibr" rid="B45">Idrees et al., 2022</xref>). Therefore, the simulations were conducted on WT-hSOD1, E49K, and R115G mutants (holo dimer forms) to assess the structural dynamic changes. The root-mean-square deviation (RMSD) was applied to quantify the difference between the initial structural conformation and the final positions of the C&#x3b1; atoms in the protein backbone. The RMSD calculation was carried out to evaluate the changes in the structure and dynamics of the modeled protein (<xref ref-type="bibr" rid="B8">Aier et al., 2016</xref>). The backbone RMSD of WT-hSOD1, E49K, and R115G mutants of the proteins were calculated over 300 ns simulations (<xref ref-type="fig" rid="F4">Figure 4A</xref>) and pointed to an unstable behavior at the beginning of simulations. After approximately 150 ns, E49K, and R115G mutants, the structures were floating in a stable state. In contrast, the RMSD value for the WT-SOD1 demonstrated fluctuation for the remainder of the MD trajectory. The average root-mean-square deviation (RMSD) values for WT-SOD1, E49K, and R115G mutants were (0.27 nm), (0.24 nm), and (0.22 nm), respectively. These changes in mutants demonstrated the loss of protein conformational deviation as compared to the WT-SOD1. Our results concerning the RMSD of SOD1 mutants align with previous research on different mutants, which exhibited a relative conformational deviation compared to the WT-SOD1 (<xref ref-type="bibr" rid="B89">Srinivasan and Rajasekaran, 2017</xref>; <xref ref-type="bibr" rid="B91">2019</xref>). Besides, hydrogen bonds, one of the most common noncovalent interactions in proteins, play an extremely important role in protein structure and function (<xref ref-type="bibr" rid="B6">Adhav and Saikrishnan, 2023</xref>). They were also the first bonds to react to the structural alterations caused by various protein mutations (<xref ref-type="bibr" rid="B9">Alemasov et al., 2017</xref>). To determine the potential impact of mutations on the conformational changes in SOD1, the number of hydrogen bonds was computed. The mean number of H-bonds for the holo dimeric WT-SOD1, E49K, and R115G mutations were 204, 202, and 199, respectively (<xref ref-type="fig" rid="F4">Figure 4B</xref>). The number of hydrogen bonds in the mutants is significantly decreased compared to the WT-SOD1, which may influence their structural stability and function, potentially leading to misfolding and aggregation. Previous studies indicate that the removal of hydrogen bonds considerably decreases the stability of SOD1 and promotes aggregation (<xref ref-type="bibr" rid="B100">Tompa et al., 2020</xref>; <xref ref-type="bibr" rid="B70">Noorbakhsh Varnosfaderani et al., 2023</xref>). Correspondingly, protein stability and the number of intramolecular interactions are both affected by the relative compactness of the protein structure, which is shown by the protein&#x2019;s radius of gyration (Rg) (<xref ref-type="bibr" rid="B108">Wise-Scira et al., 2013</xref>). According to the simulation data presented in <xref ref-type="fig" rid="F4">Figure 4C</xref>, the Rg value computed for the E49K mutant indicated a phase of structural instability, which was observed in the first half of the simulation. After approximately 150 ns, the Rg value exhibited stable behavior for the remainder of the MD trajectory. In comparison, the Rg values for both the WT-SOD1 and mutant R115G displayed initial structural instability, which persisted throughout the entirety of their respective simulations. This analysis also indicated that the average Rg values for the WT-SOD1 (2.07 nm) are relatively similar to those of mutants E49K (2.02 nm) and R115G (2.04 nm). This result suggests that there are slightly increased compactness alterations in the analyzed mutants compared to WT-SOD1. Our findings are in agreement with previous studies (<xref ref-type="bibr" rid="B49">Kalia et al., 2023</xref>). In this context, the solvent-accessible surface area (SASA) refers to the exposed regions of protein structures that are accessible to solvent molecules, a key factor in studying protein folding and stability. Amino acid residues in a protein may be categorized as exposed or buried based on their solvent-accessible surface area (SASA) values (<xref ref-type="bibr" rid="B12">Ausaf Ali et al., 2014</xref>). The SASA values acquired from all simulations (<xref ref-type="fig" rid="F4">Figure 4D</xref>) showed an unstable behavior at the beginning of all simulations. Following approximately 150 ns, the SASA values exhibited stable behavior until the end of the MD trajectories. This analysis indicated that the average SASA values for the WT-SOD1 (152.78 nm<sup>2</sup>) were similar to those of the mutants E49K (152.27 nm<sup>2</sup>) and R115G (153.21 nm<sup>2</sup>). This finding implies that no significant changes in SASA occurred among the examined mutants compared to WT-SOD1. The findings of our research are in agreement with the previous study, which indicated that no SASA alterations in the analyzed mutants when compared to the WT-SOD1 (<xref ref-type="bibr" rid="B74">Pereira et al., 2021</xref>). Next, root-mean-square fluctuation (RMSF) was used to assess the residual flexibility of the WT-SOD1 E49K and R115G mutants (holo-dimer forms). Of note, RMSF, a critical parameter, provides information about the structural flexibility of the C&#x3b1; atoms in each residue of the corresponding system through MD simulation (<xref ref-type="bibr" rid="B39">Haq et al., 2017</xref>). As seen in <xref ref-type="fig" rid="F5">Figures 5A, B</xref>, both monomers displayed asymmetric fluctuation patterns. Specifically, the WT-SOD1 has notable fluctuations in chain A at residues 62&#x2013;77, which are located in the zinc-binding region of loop IV. Notably, in the E49K and R115G mutants, all atoms contribute almost equally to their relatively stable fluctuations. The average residual RMSF for the WT-SOD1 and mutants in the A and F chains are presented in <xref ref-type="table" rid="T3">Table 3</xref>. These results suggested that WT-SOD1 is more flexible than the mutants in the holo-dimer form. We find our data to correspond with the results of the previous study, which indicated several mutants have less fluctuation relative to WT-SOD1 (<xref ref-type="bibr" rid="B91">Srinivasan and Rajasekaran, 2019</xref>). Secondary structure is a vital component in understanding the conformational stability and functionality of proteins (<xref ref-type="bibr" rid="B55">Kumar et al., 2021</xref>). The composition of secondary structures is pivotal in the aggregation process of proteins linked to neurodegenerative diseases (<xref ref-type="bibr" rid="B112">Zaji et al., 2023</xref>). Moreover, the transition of the alpha helix into beta-sheets is regarded as a primary issue in the formation of amyloid fibrils, which directly correlates with an increase in aggregation propensity (<xref ref-type="bibr" rid="B31">Dong et al., 2016</xref>; <xref ref-type="bibr" rid="B91">Srinivasan and Rajasekaran, 2019</xref>). Given this context, the analysis of the secondary structure content for the WT-SOD1, E49K, and R115G mutants was performed using the Dictionary of Secondary Structure in Proteins (DSSP) algorithm to monitor the secondary structural changes throughout the simulation (<xref ref-type="table" rid="T4">Table 4</xref>). The analysis of the results revealed that the alpha helix arrangement in E49K and R115G mutants was lower than that of WT-SOD1. Conversely, we found that the propensity of beta-sheets was slightly higher in E49K and R115G mutants compared to WT-SOD1. Consequently, we could suggest that E49K and R115G mutants compared to the WT-SOD1 have unequal proportions of different secondary structures, which might be detrimental not only in altering protein stability and function but also in inducing misfolding in SOD1, ultimately leading to protein aggregation. We found that our findings are in harmony with those identified in prior studies (<xref ref-type="bibr" rid="B112">Zaji et al., 2023</xref>; <xref ref-type="bibr" rid="B11">Ashkaran et al., 2024</xref>). A common multivariate statistical method for minimizing the number of dimensions describing the dominant protein domain motion is Principal Component Analysis (PCA) (<xref ref-type="bibr" rid="B49">Kalia et al., 2023</xref>). The projections for the MD trajectories of WT-SOD1, E49K, and R115G mutants into the subspace spanned by PC1 and PC2. As shown in <xref ref-type="fig" rid="F6">Figures 6A, B</xref>, the E49K and R115G mutants occupied a smaller area in conformational space. We also observed changes in cluster shape in the conformational space of both mutants compared to the WT-SOD1. The analysis thus pointed to alternations in the overall essential dynamics of both mutants. Our findings are in agreement with previous studies (<xref ref-type="bibr" rid="B74">Pereira et al., 2021</xref>). Cluster analysis of molecular simulation trajectories for molecular systems where the conformation and orientation of the sampled states are important parameters requires a different approach from the standard clustering methods. These systems require cluster analysis methods that discriminate based on molecular orientation and conformation. New clustering methods that account for these parameters are presented and demonstrated by the analysis of trajectories produced in protein simulations for validation (<xref ref-type="bibr" rid="B4">Abramyan et al., 2016</xref>). To better visualize the effect of mutation on SOD1 structure, we analyzed the popular conformations obtained using the clustering method with a 0.2 nm cutoff. To further compare the WT-SOD1 with the variant systems, we performed a hierarchical clustering analysis, which allowed us to compare each system with all the others. Different clustering was observed in the wild-type and mutant proteins, with cluster classifications ranging from 5 to 10. The number of clusters for the WT-SOD1, E49K, and R115G mutants was 10, 5, and 6, respectively. The fewer number of clusters may imply a faster aggregation process. On the other hand, the highest conformations for the WT-SOD1, E49K, and R115G mutants was 1916, 2,889, and 2,688, respectively. The most populated conformations are shown as cluster 1 for the WT-SOD1 and mutants in <xref ref-type="fig" rid="F7">Figure 7</xref>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>The overall structural changes in WT-SOD1, E49K, and R115G mutants during molecular dynamics simulation. <bold>(A)</bold> RMSD, <bold>(B)</bold> H-bond, <bold>(C)</bold> Rg, and <bold>(D)</bold> SASA plots of WT-SOD1 (blue line), E49K (green line), and R115G mutants (red line).</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Illustrates the RMSF of the residues of WT-SOD1, E49K, and R115G mutants. <bold>(A)</bold> RMSF (Chain A), <bold>(B)</bold> RMSF (Chain F) plots of WT-SOD1 (blue line), E49K (green line), and R115G mutants (red line).</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g005.tif"/>
</fig>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>The average value computed for RMSF of WT-SOD1 and mutants (E49K and R115G).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Protein</th>
<th align="center">RMSF average value (chain A)</th>
<th align="center">RMSF average value (chain F)</th>
</tr>
<tr>
<th colspan="2" align="center">(nm)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">WT-SOD1</td>
<td align="center">0.18</td>
<td align="center">0.15</td>
</tr>
<tr>
<td align="center">E49K</td>
<td align="center">0.13</td>
<td align="center">0.13</td>
</tr>
<tr>
<td align="center">R115G</td>
<td align="center">0.14</td>
<td align="center">0.14</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="T4" position="float">
<label>TABLE 4</label>
<caption>
<p>Percentages of the secondary structure contents of WT-SOD1 and mutants (E49K and R115G).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Protein</th>
<th align="center">Coil</th>
<th align="center">&#x3b2;-Sheet</th>
<th align="center">&#x3b2;-Bridge</th>
<th align="center">Bend</th>
<th align="center">Turn</th>
<th align="center">&#x3b1;-Helix</th>
<th align="center">3<sub>10</sub>-helix</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">WT-SOD1</td>
<td align="center">27</td>
<td align="center">38</td>
<td align="center">2</td>
<td align="center">16</td>
<td align="center">12</td>
<td align="center">3</td>
<td align="center">2</td>
</tr>
<tr>
<td align="center">E49K</td>
<td align="center">27</td>
<td align="center">39</td>
<td align="center">2</td>
<td align="center">18</td>
<td align="center">11</td>
<td align="center">1</td>
<td align="center">2</td>
</tr>
<tr>
<td align="center">R115G</td>
<td align="center">26</td>
<td align="center">39</td>
<td align="center">3</td>
<td align="center">19</td>
<td align="center">10</td>
<td align="center">1</td>
<td align="center">2</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>PCA for the WT-SOD1, E49K, and R115G mutants. The first two principal components obtained from the MD trajectories were represented as projections. <bold>(A)</bold> Comparison between the PCA projections for the WT-SOD1 (blue) and E49K mutant (green). <bold>(B)</bold> Comparison between the PCA projections for the WT-SOD1 (blue) and R115G mutant (red).</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g006.tif"/>
</fig>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>The number of clusters and observed conformations for WT-SOD1 (blue line), E49K (green line), and R115G mutants (red line) by clustering method.</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g007.tif"/>
</fig>
</sec>
<sec id="s3-1-5">
<title>3.1.5 FEL calculation</title>
<p>Protein aggregation can be well evaluated through the multiple conformational states occupied in the free energy landscape (FEL) (<xref ref-type="bibr" rid="B113">Zheng et al., 2013</xref>). Misfolding of protopathic proteins is a key biomolecular trigger for amyloid formation, ultimately leading to amyloid fibrils (<xref ref-type="bibr" rid="B5">Adamcik and Mezzenga, 2018</xref>). Accordingly, we separately evaluated the FEL for the WT-SOD1 and mutants. Similarly, a FEL was constructed to enumerate the occurrence of global energy minima constructed to investigate the pathology of the E49K and R115G mutants during the simulation period (<xref ref-type="bibr" rid="B111">Yang et al., 2013</xref>). RMSD and Rg were the two coordinates used for FEL analysis to show the compaction and structural stability of the protein during the molecular dynamics period. The Gibbs free energy of the generated FEL of WT-SOD1, E49K, and R115G mutants ranged from 0 to 10 kcal/mol, as shown in <xref ref-type="fig" rid="F8">Figure 8</xref>. The free energy ranges from purple to yellow, challenging the purple region for the minimum global energy composition and the yellow for metastable states. We concluded that the substitution mutation in SOD1 significantly altered the folding pattern, possibly leading to increased RMSD values toward the multiple energy minimum achieved by the mutant conformers. The minimum global energy number for a native protein is usually limited to one. The free energy landscape for the WT-SOD1 structure shows a unique favorable region (<xref ref-type="fig" rid="F8">Figure 8A</xref>) that lies between Rg and RMSD values of &#x223c;2.08 nm and &#x223c;0.38 nm, respectively. The results for the E49K mutant showed a global energy minimum that could occur in more compact conformational states, each of which could cause misfolding and lead to aggregation. The formation of favorable free energy domains (<xref ref-type="fig" rid="F8">Figure 8B</xref>) was 2.02 and &#x223c;0.23 nm for Rg and RMSD, respectively. However, results for the R115G mutant protein indicated multiple global energy minima that could occur in various thermodynamically conceivable conformational states, any of which can lead to aggregation. The effect of substitution mutation on this process led to the formation of numerous favorable free energy basins (<xref ref-type="fig" rid="F8">Figure 8C</xref>), which were &#x223c;2.03 and &#x223c;0.25 nm for Rg and RMSD, respectively. Hence, as the free energy profile showed, the presence of R115 in the wild-type plays a prominent role in the presence of the limited free energy basin along RMSD and Rg, which by replacing Gly led to the change of SOD1 proteins and reaching several global free energy minima. Furthermore, the free energy domain obtained by WT-SOD1 was smaller than the conformational structures of the R115G mutant, indicating a more favorable conformation adopted by the wild-type conformers than the mutant. Altogether, the results support the idea that an increased percentage of multiple conformers with lower free energy in the mutant than the wild-type are directed toward forming predominantly unfolded states. Furthermore, in confirmation of our results indirectly compared to previous studies, it suggests that the aggregated proteins acquire the minimum multiple energy for the conformational structures that indicate the formation of toxic aggregates in mutant SOD1 (<xref ref-type="bibr" rid="B59">Maitham Qassim et al., 2023</xref>; <xref ref-type="bibr" rid="B70">Noorbakhsh Varnosfaderani et al., 2023</xref>; <xref ref-type="bibr" rid="B2">Abdullah Waheed et al., 2024</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Free energy landscape. FEL for the <bold>(A)</bold> WT-SOD1, <bold>(B)</bold> E49K, and <bold>(C)</bold> R115G mutants. The FEL was constructed with Rg and RMSD as reaction coordinates and energy in Z-axes with values illustrated in the color bar.</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g008.tif"/>
</fig>
</sec>
<sec id="s3-1-6">
<title>3.1.6 Quantification of SOD1 dimerization using MM/PBSA and per-residue free energy decomposition</title>
<p>The MM-PBSA strategy for binding free energy estimation has become one of the most adopted techniques to measure interaction energies in biomolecular studies (<xref ref-type="bibr" rid="B107">Wang et al., 2019</xref>). To quantify SOD1 dimerization in terms of energy, an analysis of MM-PBSA was performed. The results identified the WT-SOD1 system as the most stable form with the highest binding energy, &#x2212;105.17 kcal/mol. The results further suggested that E49K and R115G mutants compromised the dimerization potential between monomers, leading to reduced binding energies of &#x2212;32.1 and &#x2212;79.47 kcal/mol, respectively. The binding energies in the mutants are significantly decreased compared to the WT-SOD1, which may influence their dimer structural stability, potentially leading to aggregation. Our results concerning the MM-PBSA of SOD1 mutants align with previous research on several mutants, which exhibited mutations that compromised the dimerization potential between monomers, leading to reduced binding energies compared to WT-SOD1 (<xref ref-type="bibr" rid="B14">Basith et al., 2022</xref>). The technique of per-residue binding free energy decomposition can reveal the contributions of the key residues responsible for the protein-protein interactions at the interface. A total of 1,000 frames extracted from the last 50 ns of the MD trajectories were decomposed by the MM-PBSA method. The analysis of free energy decomposition was performed on the WT-SOD1 and mutants. Free energy decomposition analysis helps to find the contribution of a single residue by summing its interactions over the entire residues. The results of this study showed that in the wild-type state (<xref ref-type="fig" rid="F9">Figure 9A</xref>), the binding free energy for residues E49 and R115 in chain-A was 0.64 and &#x2212;4.27 kJ/mol, respectively. For chain-F, the binding energy values for residues E49 and R115 were 0.06 and 0.26 kJ/mol, respectively. The E49K mutation (<xref ref-type="fig" rid="F9">Figure 9B</xref>) changed the binding free energy value, which was 9.31 and 7.25 kJ/mol in the A and F chains, respectively. On the other hand, the binding free energy values for the R115G mutation (<xref ref-type="fig" rid="F9">Figure 9C</xref>) were &#x2212;3.26 and &#x2212;3.43 kJ/mol in chains A and F, respectively. The analysis thus pointed to alternations in the per-residue free energy decomposition of both mutants compared to the WT-SOD1, which may influence their dimer structural stability, potentially leading to aggregation.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Per-residue decomposition of the binding free energy for the <bold>(A)</bold> WT-SOD1, <bold>(B)</bold> E49K, and <bold>(C)</bold> R115G mutants in chains A (blue line) and F (red line).</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g009.tif"/>
</fig>
</sec>
</sec>
<sec id="s3-2">
<title>3.2 Experimental section</title>
<sec id="s3-2-1">
<title>3.2.1 Enzymatic activity assay</title>
<p>Almost all mutations in SOD1-amyotrophic lateral sclerosis result in a significant decrease in SOD1 enzyme activity, according to published data from individuals with this disease (<xref ref-type="bibr" rid="B85">Saccon et al., 2013</xref>). The active site of the SOD1 protein contains a Cu<sup>2&#x2b;</sup> ion coordinated with four histidine residues: His 46, His 48, His 120, and His 63 (<xref ref-type="bibr" rid="B51">Keerthana and Kolandaivel, 2015</xref>). The enzymatic activity of WT-hSOD1, E49K, and R115G mutants was 7,031, 5,536, and 4305 U/mg, respectively. The results of our study revealed reduced enzymatic activity for E49K and R115G compared to holo WT-hSOD1. At position 49, glutamic acid has a negative charge and is vital for setting up the electrostatic environment that His48 needs to coordinate the copper ion. This contact is essential for the enzyme&#x2019;s performance. The E49K mutation substitutes essential glutamic acid with positively charged lysine. This change may substantially disturb the delicate balance necessary for the correct coordination of the his48 with the copper ion. On the other hand, the R115G mutation diminishes the van der Waals interaction with His48. The lack of this interaction may further affect the structural integrity and activity of the enzyme, especially considering the significance of copper coordination at the His48 location. Initially, researchers believed that ALS-causing SOD1 mutations altered the protein&#x2019;s structure, resulting in an unstable or misfolded enzyme that lowered dismutase activity and heightened oxidative stress. However, different FALS-linked SOD1 mutations had different amounts of dismutase activity. This suggests that mutant SOD1&#x2019;s toxicity could not be explained by a simple loss of function. Additionally, there are no FALS patients known to have mutations resulting in complete loss of SOD1 (<xref ref-type="bibr" rid="B13">Barber et al., 2006</xref>). Our results correspond with previous investigations indicating that the specific activity of several SOD1 mutants is decreased in comparison to the WT-SOD1 (<xref ref-type="bibr" rid="B62">Mavadat et al., 2023b</xref>; <xref ref-type="bibr" rid="B11">Ashkaran et al., 2024</xref>).</p>
</sec>
<sec id="s3-2-2">
<title>3.2.2 Fluorescence and FTIR spectroscopy analysis</title>
<p>Among the aromatic amino acids (Trp, Tyr, and Phe), intrinsic Trp fluorescence is the most often used method to track local structural and dynamic changes in proteins (<xref ref-type="bibr" rid="B80">Raghuraman et al., 2019</xref>). WT-hSOD1 only possesses one Trp at residue 32 (W32), which is highly solvent-exposed (<xref ref-type="bibr" rid="B37">Grad et al., 2011</xref>). <xref ref-type="fig" rid="F10">Figure 10A</xref>, A shows the intrinsic fluorescence of the E49K mutant is lower than that of WT-hSOD1, indicating that the environment of the single solvent-exposed Trp residue 32 is not buried. In other words, the polarity of the Trp residue microenvironment increased and was more exposed to the solvent. The R115G mutant fluorescence spectrum shows an increase in fluorescence intensity with a change of &#x3bb;max in the emission spectra and a blue shift compared to the wild-type, showing that the alterations in the circumambient environment, the tryptophan (W32), toward a more hydrophobic environment. The ability to measure the hydrophobicity of a protein may be advantageous in comprehending and forecasting the implications of alterations to the sequence of its structure. The increased ANS fluorescence signified that ANS bound to the exposed contiguous hydrophobic regions (<xref ref-type="bibr" rid="B24">Cardamone and Puri, 1992</xref>; <xref ref-type="bibr" rid="B46">Idrees et al., 2016</xref>). The hydrophobic inner core of the monomer SOD1 contains roughly half of the protein backbone (<xref ref-type="bibr" rid="B109">Wright et al., 2019</xref>), and protein dimerization provides approximately 640 &#xc5; of hydrophobic surface area at the dimer interface through a complex network of hydrogen bonds and hydrophobic interactions, resulting in a compact mature homodimer with minimal solvent accessibility. Accordingly, holo-SOD1 is one of the most stable proteins known (<xref ref-type="bibr" rid="B102">Trist et al., 2021</xref>). To evaluate the impact of mutations on changes in SOD1&#x2019;s hydrophobicity, ANS fluorescence was utilized. As shown in <xref ref-type="fig" rid="F10">Figure 10B</xref>, the ANS fluorescence of E49K and R115G indicates a significant increase compared to the WT-SOD1, indicating the role of mutations in conformational changes and increased amounts of exposed hydrophobic surfaces. Our findings are in agreement with previous studies (<xref ref-type="bibr" rid="B68">Namadyan et al., 2023</xref>). FTIR, which is known as one of the accurate techniques for reflecting the secondary structure of proteins, was used to study misfolding and aggregate formation (<xref ref-type="bibr" rid="B64">Miller et al., 2013</xref>). Accordingly, the formation of &#x3b2;-sheet structures in WT-SOD1 and the mutants (under destabilizing conditions) was confirmed by FTIR spectroscopy (<xref ref-type="fig" rid="F10">Figures 10C&#x2013;E</xref>). The FTIR spectra were also employed to distinguish between types of &#x3b2;-sheet structures and the amyloidogenic conformers (amide I bands) were then determined. According to <xref ref-type="table" rid="T5">Table 5</xref>, the peak in 1,610&#x2013;1,630 cm<sup>&#x2212;1</sup>, indicating the formation of fibrils and &#x3b2;-oligomers with the intermolecular &#x3b2;-sheet structure due to protein aggregation, was reported for WT-SOD1 and mutants. The native &#x3b2;-sheets could produce an absorption peak in the 1,623&#x2013;1,641 cm<sup>&#x2212;1</sup> range. Examining the amide (I) bands, a parallel arrangement could be thus marked in the anti-parallel arrangement of the &#x3b2;-strands in the protein aggregates. In this line, the parallel &#x3b2;-sheets could display only an elevated component at 1,623&#x2013;1,641 cm<sup>&#x2212;1</sup> (<xref ref-type="bibr" rid="B41">Hoffner et al., 2014</xref>). The disordered conformation (random coil) is usually associated with the IR band between 1,640 and 1,648 cm<sup>&#x2212;1</sup>. A distinctive feature of a random coil is that it is non-repetitive. Such an assignment is supported by the position of a prominent band in the spectrum of apparently disordered proteins (<xref ref-type="bibr" rid="B20">Byler and Susi, 1986</xref>). A component centered at approximately 1,650&#x2013;1,660 cm<sup>&#x2212;1</sup> is assigned to the &#x3b1;-helix, which is consistent with theoretical calculations and the observation of bands in the spectrum of &#x3b1;-helix proteins (<xref ref-type="bibr" rid="B86">Sadat and Joye, 2020</xref>). &#x3b1;-Helix structure was observed for WT-SOD1 at peak position 1,655, cm<sup>&#x2212;1</sup>. On the other hand, &#x3b1;-helical structure (3<sub>10</sub>-helix) was observed for the E49K and R115G mutants at peak positions of 1,666 and 1,664 cm<sup>&#x2212;1</sup>, respectively. Bands near 1,663 &#xb1; 3 cm<sup>&#x2212;1</sup> are assigned to 3<sub>10</sub> helices, although this structure is rarely found in proteins (<xref ref-type="bibr" rid="B30">Dong et al., 1990</xref>). The 3<sub>10</sub>-helix structure is classified as a subset of the &#x3b1;-helix and appears in proteins when the &#x3b1;-helix is distorted due to the presence of (mutation) an undesirable residue (<xref ref-type="bibr" rid="B75">Peters, 2005</xref>). The assignment of bands around 1,670&#x2013;1,699 cm<sup>&#x2212;1</sup> to &#x3b2;-turns has been suggested (<xref ref-type="bibr" rid="B54">Krimm and Bandekar, 1986</xref>). Hence, the &#x3b2;-turn structure was observed for the E49K and R115G mutants in the peak region of 1,682 and 1,679 cm<sup>&#x2212;1</sup>, respectively. Therefore, the FTIR spectroscopy results showed that the mutants have different changes in the natural &#x3b2;-sheet structure of the protein compared to the wild-type. Therefore, the changes in the secondary structure of the SOD1 variants indicate a structural rearrangement of SOD1, potentially leading to aggregation. The results are consistent with what has been previously reported (<xref ref-type="bibr" rid="B11">Ashkaran et al., 2024</xref>; <xref ref-type="bibr" rid="B33">Farrokhzad et al., 2024</xref>).</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Structural characteristics of WT-hSOD1 and mutants of SOD1 (E49K, R115G) by <bold>(A)</bold> intrinsic fluorescence and <bold>(B)</bold> extrinsic fluorescence emission in phosphate buffer. Results of a Fourier self-deconvolution (FSD) analysis on the amide I (1,600&#x2013;1,700 cm<sup>&#x2212;1</sup> region) for <bold>(C)</bold> WT-SOD1, <bold>(D)</bold> E49K, and <bold>(E)</bold> R115G mutants. The assignment of different peaks to different secondary structure elements is shown. Protein concentration was 25 &#x3bc;M in the presence of amyloidogenic conditions. For further details, please refer to the <italic>Materials and Methods</italic> section.</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g010.tif"/>
</fig>
<table-wrap id="T5" position="float">
<label>TABLE 5</label>
<caption>
<p>Assignment of amide I band components and percentages of secondary structure contents in WT-SOD1 and mutants (E49K and R115G).</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Protein</th>
<th align="center">Corresponding secondary structure</th>
<th align="center">Observed negative peaks (cm<sup>&#x2212;1</sup>)</th>
<th align="center">Secondary structure (%)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="3" align="center">WT-SOD1</td>
<td align="center">&#x3b2;-Sheet (aggregated)</td>
<td align="center">
<bold>1,626</bold>
</td>
<td align="center">25.22</td>
</tr>
<tr>
<td align="center">&#x3b2;-Sheet</td>
<td align="center">1,638</td>
<td align="center">31.56</td>
</tr>
<tr>
<td align="center">&#x3b1;-Helix</td>
<td align="center">1,655</td>
<td align="center">43.22</td>
</tr>
<tr>
<td rowspan="4" align="center">E49K</td>
<td align="center">&#x3b2;-Sheet (aggregated)</td>
<td align="center">
<bold>1,623</bold>
</td>
<td align="center">31</td>
</tr>
<tr>
<td align="center">Random coil</td>
<td align="center">1,647</td>
<td align="center">55.81</td>
</tr>
<tr>
<td align="center">&#x3b1;-Helix (3<sub>10</sub> helix)</td>
<td align="center">1,666</td>
<td align="center">7.19</td>
</tr>
<tr>
<td align="center">&#x3b2;-Turn</td>
<td align="center">1,682</td>
<td align="center">6</td>
</tr>
<tr>
<td rowspan="4" align="center">R115G</td>
<td align="center">&#x3b2;-Sheet (aggregated)</td>
<td align="center">
<bold>1,625</bold>
</td>
<td align="center">38.39</td>
</tr>
<tr>
<td align="center">Random coil</td>
<td align="center">1,644</td>
<td align="center">32.9</td>
</tr>
<tr>
<td align="center">&#x3b1;-Helix (3<sub>10</sub> helix)</td>
<td align="center">1,664</td>
<td align="center">26.54</td>
</tr>
<tr>
<td align="center">&#x3b2;-Turn</td>
<td align="center">1,679</td>
<td align="center">2.17</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Note: Bolded values indicate &#x3b2;-sheet (due to aggregation) or cross-&#x3b2; structure.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2-3">
<title>3.2.3 Fluorescence spectroscopy analysis under destabilizing circumstances</title>
<p>To obtain a deeper understanding about the relationship between aggregate formation and changes in the Trp environment, we looked at the intrinsic fluorescence of pathological aggregates formed from wild-type and mutants under destabilizing circumstances. Obtained data indicated that fluorescence intensity in both mutants during aggregation compared to wild-type shows that Trp-32 is not buried. In other words, the polarity of the Trp residue microenvironment increased and was more exposed to the solvent, as seen in <xref ref-type="fig" rid="F11">Figure 11A</xref>. To evaluate the impact of mutations on changes in SOD1&#x2019;s hydrophobicity, as well as to observe the exposure of hydrophobic pockets in &#x3b2;-sheet structures during aggregation formation, ANS fluorescence was utilized. Several factors, such as formulation conditions, protein sequences, and structure, influence protein aggregation. The classical hydrophobic effect drives the interaction of exposed hydrophobic pockets on the protein surface, leading to the formation of protein aggregates (<xref ref-type="bibr" rid="B101">Tosstorff et al., 2019</xref>). According to <xref ref-type="fig" rid="F11">Figure 11B</xref>, ANS fluorescence emission of mutants under amyloid induction conditions showed lower emission intensity than WT-SOD1. The decrease in ANS fluorescence intensity is probably due to the coverage of large parts of the exposed hydrophobic surfaces, which results from the interaction of hydrophobic segments between protein molecules during the amyloid process. These results are aligned with observations noted in earlier studies (<xref ref-type="bibr" rid="B1">Abbasabadi et al., 2013</xref>; <xref ref-type="bibr" rid="B87">Salehi et al., 2015</xref>; <xref ref-type="bibr" rid="B15">Baziyar et al., 2022</xref>; <xref ref-type="bibr" rid="B62">Mavadat et al., 2023b</xref>).</p>
<fig id="F11" position="float">
<label>FIGURE 11</label>
<caption>
<p>Structural characteristics of WT-hSOD1 and mutants of SOD1 (E49K, R115G) by <bold>(A)</bold> intrinsic fluorescence and <bold>(B)</bold> extrinsic fluorescence emission in the presence of amyloidogenic conditions. For further details, please refer to the <italic>Materials and Methods</italic> section.</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g011.tif"/>
</fig>
</sec>
<sec id="s3-2-4">
<title>3.2.4 ThT fluorescence assay</title>
<p>The end-point level of ThT fluorescence intensity has been on mature fibrils, as generally reported. A growing number of structural models for amyloid fibrils thus strongly suggest that ThT binds to the long axis of fibril by aligning parallel, intercalating to the repeating side-chain interactions running across &#x3b2;-strands within the &#x3b2;-sheet layer (<xref ref-type="bibr" rid="B110">Wu et al., 2009</xref>). In this study, WT-SOD1 and mutants were incubated under inducing conditions for time intervals of 0&#x2013;72 h with and without agitation. Once NaCl was substituted for KSCN, no amyloid was formed. This implied that the effect of KSCN was related to its chaotropic properties but not its impact on ionic strength. The representative fluorescence time courses for the WT-SOD1 and mutants are illustrated in <xref ref-type="fig" rid="F12">Figure 12</xref> and a complete set of the kinetic parameters are then given in <xref ref-type="table" rid="T6">Table 6</xref>. The results showed that the WT-SOD1 and mutants formed amyloid aggregates when there were high concentrations of DTT. Furthermore, experiments showed that SOD1 fibrillation preceded the growth in ThT fluorescence, which was different in mutant and WT-SOD1. This delay was different in mutants and WT-SOD1. Comparison of the lag phases showed that the mutants tended to have shorter lag phases and faster fibrillation than holoWT-SOD1. This step increased thioflavin T fluorescence to different levels for WT-SOD1 and mutants. However, this change in lag was shown to be compatible with other reported results that have been studied under different settings (<xref ref-type="bibr" rid="B1">Abbasabadi et al., 2013</xref>; <xref ref-type="bibr" rid="B87">Salehi et al., 2015</xref>). In particular, FALS-causing mutations wouldn&#x27;t always reduce the latency and/or increase the aggregation propensity of SOD1. In addition, the kinetics of amyloid fibril aggregation is delayed, with an initial increase in ThT fluorescence intensity, which was more pronounced for mutants than for WT-SOD1, followed by a decrease in ThT intensity. This may be due to the formation of mat-like aggregates of fibrils, resulting in a number of modified or unavailable binding sites for ThT. This difference in the kinetics of aggregate formation in the mutant forms may be due to the amino acid substitution. Finally, when the ThT fluorescence intensity reaches its maximum, the plateau phase begins. However, this stage does not last long because amyloid fibers tend to form web-like network structures. The findings of our study may support the idea that SOD1 aggregation occurs through a pathway including weakening of the dimer interface, dimer dissociation, reducing the binding/affinity of metal ions from monomers, and aggregation of monomers (<xref ref-type="bibr" rid="B97">Tiwari and Hayward, 2003</xref>; <xref ref-type="bibr" rid="B43">Hough et al., 2004</xref>). Furthermore, the results show that SOD1 forms amyloid aggregates under different conditions including agitation, ionic strength, temperature and physiological pH. We were able to demonstrate the potential of WT-SOD1 and mutants to form amyloid structures under conditions inducing amyloid aggregation. These results are consistent with previous studies showing the importance of fibrillation or oligomerization of SOD1 in the pathogenesis of ALS (<xref ref-type="bibr" rid="B71">Oztug Durer et al., 2009</xref>; <xref ref-type="bibr" rid="B1">Abbasabadi et al., 2013</xref>; <xref ref-type="bibr" rid="B87">Salehi et al., 2015</xref>; <xref ref-type="bibr" rid="B15">Baziyar et al., 2022</xref>).</p>
<fig id="F12" position="float">
<label>FIGURE 12</label>
<caption>
<p>Kinetics of WT-SOD1, E49K and R115G mutants&#x2019; amyloid aggregation Formation using ThT fluorescence incubated in the presence of 30 &#x3bc;M protein in 20 mM phosphate buffer, ThT concentration 20 &#x3bc;M and under induction conditions (DTT 50 mM, Tris-HCl 50 mM, KSCN 0.16 M) pH 7.4 at 37&#xb0;C with and without agitation at 190 rpm. Data are from two independent replicates.</p>
</caption>
<graphic xlink:href="fmolb-12-1532375-g012.tif"/>
</fig>
<table-wrap id="T6" position="float">
<label>TABLE 6</label>
<caption>
<p>Kinetic parameters of amyloid aggregation formation from WT-SOD1 and mutants in 50 mM Tris-HCl, 0.16 M KSCN, and 50 mM DTT at pH 7.4 with agitation at 190 rpm at 37&#xb0;C.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Protein</th>
<th align="center">Lag time (h)</th>
<th align="center">K<sub>app</sub> (h<sup>&#x2212;1</sup>)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">WT-SOD1</td>
<td align="center">32 &#xb1; 3</td>
<td align="center">0.111 &#xb1; 0.025</td>
</tr>
<tr>
<td align="center">E49K</td>
<td align="center">26 &#xb1; 2</td>
<td align="center">0.181 &#xb1; 0.013</td>
</tr>
<tr>
<td align="center">R115G</td>
<td align="center">27 &#xb1; 4</td>
<td align="center">0.166 &#xb1; 0.028</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>4 Conclusion</title>
<p>The present study focused on investigating the potential effect of the two-point mutations at the surface (namely, E49K and R115G), which are located in metal-binding loop IV and Greek key loop VI, respectively, on the structure and dynamics of the SOD1 molecule using computational predictions, molecular dynamics simulations, and experimental studies. The <italic>in silico</italic> analysis utilizing various algorithms revealed a high rate of deleterious and destabilizing predictions for these mutants, suggesting their harmful effects. The findings obtained for the molecular modeling showed that E49K and R115G mutants significantly changed the distribution of the net negative charge and interaction of adjacent amino acids, respectively, compared to the WT-SOD1, which could reduce the stability of the SOD1 dimer, promoting aberrant interactions and misfolding. The MD analyses of variants E49K and R115G pointed to structural destabilization by affecting the increased content of &#x3b2;-sheet structures and loss of hydrogen bonds that could lead to protein misfolding. Furthermore, the results of the experimental section demonstrated that hSOD1 mutations change the protein structure and conformation, which leads to exposing hydrophobic pockets that would typically be buried within the core of the protein structure which could affect the stability and ultimately promote protein aggregation. In addition, experimental analysis illustrated that conformational changes in mutants could affect the enzyme activity compared to the WT-SOD1. In summary, our study highlights key differences in the structure and dynamics of investigated SOD1 variants and WT-hSOD1. It sheds light on the behavior of SOD1 variants at an atomic and molecular level, suggesting that mutations in the metal-binding loop IV and Greek key loop VI lead to induced significant structural and conformational changes that could affect the structure and stability of the SOD1 molecule, which ultimately results in enhanced formation of toxic aggregates and the pathology of ALS. The structural insights obtained from this study will assist future experimental and computational research focused on targeted therapies. This study elucidated the processes of protein instability and aggregation, establishing a basis for the investigation of therapeutic agents that may stabilize SOD1 mutants or prevent and/or decrease protein aggregate formation related to ALS disease.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="s6">
<title>Author contributions</title>
<p>SH: Data curation, Investigation, Methodology, Validation, Writing&#x2013;original draft. BS: Conceptualization, Data curation, Formal Analysis, Investigation, Supervision, Validation, Visualization, Writing&#x2013;review and editing. NK: Data curation, Writing&#x2013;original draft. KR: Data curation, Writing&#x2013;original draft. PB: Writing&#x2013;review and editing, Data curation, Formal Analysis. SH: Conceptualization, Data curation, Validation, Writing&#x2013;original draft.</p>
</sec>
<sec sec-type="funding-information" id="s7">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<p>The authors would like to express their gratitude to the Research Council of Mazandaran University for their partial support in this work.</p>
</ack>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s9">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbasabadi</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Javanian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nikkhah</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meratan</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Ghiasi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nemat-Gorgani</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Disruption of mitochondrial membrane integrity induced by amyloid aggregates arising from variants of SOD1</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>61</volume>, <fpage>212</fpage>&#x2013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2013.07.007</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdullah Waheed</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hosseinzadeh Colagar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Baziyar</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Exploring the anti-amyloid potential of salvianolic acid A against the ALS-associated mutant SOD1: insights from molecular docking and molecular dynamic simulations</article-title>. <source>Mol. Simul.</source> <volume>50</volume>, <fpage>899</fpage>&#x2013;<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1080/08927022.2024.2365377</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abel</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>J. F.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Al&#x2010;Chalabi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>ALSoD: a user&#x2010;friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics</article-title>. <source>Hum. Mutat.</source> <volume>33</volume> (<issue>9</issue>), <fpage>1345</fpage>&#x2013;<lpage>1351</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22157</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abramyan</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Snyder</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Thyparambil</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Stuart</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Latour</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Cluster analysis of molecular simulation trajectories for systems where both conformation and orientation of the sampled states are important</article-title>. <source>J. Comput. Chem.</source> <volume>37</volume> (<issue>21</issue>), <fpage>1973</fpage>&#x2013;<lpage>1982</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.24416</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adamcik</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mezzenga</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Amyloid polymorphism in the protein folding and aggregation energy landscape</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>57</volume> (<issue>28</issue>), <fpage>8370</fpage>&#x2013;<lpage>8382</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201713416</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adhav</surname>
<given-names>V. A.</given-names>
</name>
<name>
<surname>Saikrishnan</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The realm of unconventional noncovalent interactions in proteins: their significance in structure and function</article-title>. <source>Acs Omega</source> <volume>8</volume> (<issue>25</issue>), <fpage>22268</fpage>&#x2013;<lpage>22284</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.3c00205</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Sunyaev</surname>
<given-names>S. R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Predicting functional effect of human missense mutations using PolyPhen&#x2010;2</article-title>. <source>Curr. Protoc. Hum. Genet.</source> <volume>76</volume> (<issue>1</issue>), <fpage>Unit7.20</fpage>&#x2013;<lpage>27.20. 41</lpage>. <pub-id pub-id-type="doi">10.1002/0471142905.hg0720s76</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aier</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Varadwaj</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Structural insights into conformational stability of both wild-type and mutant EZH2 receptor</article-title>. <source>Sci. Rep.</source> <volume>6</volume> (<issue>1</issue>), <fpage>34984</fpage>. <pub-id pub-id-type="doi">10.1038/srep34984</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alemasov</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Ivanisenko</surname>
<given-names>N. V.</given-names>
</name>
<name>
<surname>Ivanisenko</surname>
<given-names>V. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Regression model for predicting pathogenic properties of SOD1 mutants based on the analysis of conformational stability and conservation of hydrogen bonds</article-title>. <source>J. Mol. Graph. Model.</source> <volume>77</volume>, <fpage>378</fpage>&#x2013;<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmgm.2017.09.014</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonyuk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Elam</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Hough</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Strange</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Doucette</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>J. A.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg</article-title>. <source>Protein Sci.</source> <volume>14</volume> (<issue>5</issue>), <fpage>1201</fpage>&#x2013;<lpage>1213</lpage>. <pub-id pub-id-type="doi">10.1110/ps.041256705</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashkaran</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baziyar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hosseinkhani</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Mutation/metal deficiency in the &#x201c;electrostatic loop&#x201d; enhanced aggregation process in apo/holo SOD1 variants: implications for ALS diseases</article-title>. <source>BMC Chem.</source> <volume>18</volume> (<issue>1</issue>), <fpage>177</fpage>. <pub-id pub-id-type="doi">10.1186/s13065-024-01289-x</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ausaf Ali</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Imtaiyaz Hassan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states</article-title>. <source>Curr. Protein Peptide Sci.</source> <volume>15</volume> (<issue>5</issue>), <fpage>456</fpage>&#x2013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.2174/1389203715666140327114232</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barber</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Mead</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>P. J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target</article-title>. <source>Biochimica Biophysica Acta (BBA)-Molecular Basis Dis.</source> <volume>1762</volume> (<issue>11-12</issue>), <fpage>1051</fpage>&#x2013;<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2006.03.008</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basith</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Manavalan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Amyotrophic lateral sclerosis disease-related mutations disrupt the dimerization of superoxide dismutase 1-A comparative molecular dynamics simulation study</article-title>. <source>Comput. Biol. Med.</source> <volume>151</volume>, <fpage>106319</fpage>. <pub-id pub-id-type="doi">10.1016/j.compbiomed.2022.106319</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baziyar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hosseinkhani</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Zinc binding loop mutations of hSOD1 promote amyloid fibrils under physiological conditions: implications for initiation of amyotrophic lateral sclerosis</article-title>. <source>Biochimie</source> <volume>199</volume>, <fpage>170</fpage>&#x2013;<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2022.05.001</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bendl</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stourac</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Salanda</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Pavelka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wieben</surname>
<given-names>E. D.</given-names>
</name>
<name>
<surname>Zendulka</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations</article-title>. <source>PLoS Comput. Biol.</source> <volume>10</volume> (<issue>1</issue>), <fpage>e1003440</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1003440</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berman</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gilliland</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>T. N.</given-names>
</name>
<name>
<surname>Weissig</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>The protein data bank</article-title>. <source>Nucleic acids Res.</source> <volume>28</volume> (<issue>1</issue>), <fpage>235</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boukaftane</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Khoris</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moulard</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Salachas</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Meininger</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Malafosse</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Identification of six novel SOD1 gene mutations in familial amyotrophic lateral sclerosis</article-title>. <source>Can. J. neurological Sci.</source> <volume>25</volume> (<issue>3</issue>), <fpage>192</fpage>&#x2013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1017/s0317167100034004</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bromberg</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Rost</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>SNAP: predict effect of non-synonymous polymorphisms on function</article-title>. <source>Nucleic acids Res.</source> <volume>35</volume> (<issue>11</issue>), <fpage>3823</fpage>&#x2013;<lpage>3835</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkm238</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byler</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Susi</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Examination of the secondary structure of proteins by deconvolved FTIR spectra</article-title>. <source>Biopolymers Orig. Res. Biomol.</source> <volume>25</volume> (<issue>3</issue>), <fpage>469</fpage>&#x2013;<lpage>487</lpage>. <pub-id pub-id-type="doi">10.1002/bip.360250307</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bystr&#xf6;m</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Gr&#xf6;bner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Oliveberg</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>SOD1 mutations targeting surface hydrogen bonds promote amyotrophic lateral sclerosis without reducing apo-state stability</article-title>. <source>J. Biol. Chem.</source> <volume>285</volume> (<issue>25</issue>), <fpage>19544</fpage>&#x2013;<lpage>19552</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M109.086074</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capriotti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Calabrese</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Casadio</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information</article-title>. <source>Bioinformatics</source> <volume>22</volume> (<issue>22</issue>), <fpage>2729</fpage>&#x2013;<lpage>2734</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btl423</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capriotti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Fariselli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Casadio</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>I-Mutant2. 0: predicting stability changes upon mutation from the protein sequence or structure</article-title>. <source>Nucleic acids Res.</source> <volume>33</volume> (<issue>Suppl. l_2</issue>), <fpage>W306</fpage>&#x2013;<lpage>W310</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki375</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardamone</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Puri</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Spectrofluorimetric assessment of the surface hydrophobicity of proteins</article-title>. <source>Biochem. J.</source> <volume>282</volume> (<issue>2</issue>), <fpage>589</fpage>&#x2013;<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1042/bj2820589</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.-W.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>Y.-W.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>iStable: off-the-shelf predictor integration for predicting protein stability changes</article-title>. <source>BMC Bioinforma.</source> <volume>14</volume>, <fpage>S5</fpage>&#x2013;<lpage>S14</lpage>. <pub-id pub-id-type="doi">10.1186/1471-2105-14-S2-S5</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Leng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Gui</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Computational analysis of androgen receptor (AR) variants to decipher the relationship between protein stability and related-diseases</article-title>. <source>Sci. Rep.</source> <volume>10</volume> (<issue>1</issue>), <fpage>12101</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-68731-7</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chowdhury</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Uversky</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Maulik</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Chattopadhyay</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Network mapping of the conformational heterogeneity of SOD1 by deploying statistical cluster analysis of FTIR spectra</article-title>. <source>Cell. Mol. life Sci.</source> <volume>76</volume>, <fpage>4145</fpage>&#x2013;<lpage>4154</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-019-03108-2</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Consortium</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>UniProt: a hub for protein information</article-title>. <source>Nucleic acids Res.</source> <volume>43</volume> (<issue>D1</issue>), <fpage>D204</fpage>&#x2013;<lpage>D212</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku989</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Da Silva</surname>
<given-names>A. N. R.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>G. R. C.</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>L. G. A.</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>De Mesquita</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>SOD1 in amyotrophic lateral sclerosis development&#x2013;<italic>in silico</italic> analysis and molecular dynamics of A4F and A4V variants</article-title>. <source>J. Cell. Biochem.</source> <volume>120</volume> (<issue>10</issue>), <fpage>17822</fpage>&#x2013;<lpage>17830</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.29048</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Caughey</surname>
<given-names>W. S.</given-names>
</name>
</person-group> (<year>1990</year>). <article-title>Protein secondary structures in water from second-derivative amide I infrared spectra</article-title>. <source>Biochemistry</source> <volume>29</volume> (<issue>13</issue>), <fpage>3303</fpage>&#x2013;<lpage>3308</lpage>. <pub-id pub-id-type="doi">10.1021/bi00465a022</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ai</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Molecular dynamics study on the inhibition mechanisms of drugs CQ1-3 for alzheimer amyloid-&#x3b2;40 aggregation induced by Cu(2.)</article-title>. <source>ACS Chem. Neurosci.</source> <volume>7</volume> (<issue>5</issue>), <fpage>599</fpage>&#x2013;<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1021/acschemneuro.5b00343</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esmaeili</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghobadi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Akbari</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Moradi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shahlaie</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ghobadi</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Pyridine-2, 3-dicarboxylate, quinolinic acid, induces 1N4R Tau amyloid aggregation <italic>in vitro</italic>: another evidence for the detrimental effect of the inescapable endogenous neurotoxin</article-title>. <source>Chemico-biological Interact.</source> <volume>315</volume>, <fpage>108884</fpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2019.108884</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farrokhzad</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baziyar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hosseinkhani</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Insight into factors influencing the aggregation process in wild&#x2010;type and P66R mutant SOD1: computational and spectroscopic approaches</article-title>. <source>Proteins Struct. Funct. Bioinforma.</source> <pub-id pub-id-type="doi">10.1002/prot.26765</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghisaidoobe</surname>
<given-names>A. B.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Intrinsic tryptophan fluorescence in the detection and analysis of proteins: a focus on F&#xf6;rster resonance energy transfer techniques</article-title>. <source>Int. J. Mol. Sci.</source> <volume>15</volume> (<issue>12</issue>), <fpage>22518</fpage>&#x2013;<lpage>22538</lpage>. <pub-id pub-id-type="doi">10.3390/ijms151222518</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghosh</surname>
<given-names>D. K.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ranjan</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>T54R mutation destabilizes the dimer of superoxide dismutase 1 T54R by inducing steric clashes at the dimer interface</article-title>. <source>Rsc Adv.</source> <volume>10</volume> (<issue>18</issue>), <fpage>10776</fpage>&#x2013;<lpage>10788</lpage>. <pub-id pub-id-type="doi">10.1039/c9ra09870d</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gitlin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Carbeck</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Whitesides</surname>
<given-names>G. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Why are proteins charged? Networks of charge&#x2013;charge interactions in proteins measured by charge ladders and capillary electrophoresis</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>45</volume> (<issue>19</issue>), <fpage>3022</fpage>&#x2013;<lpage>3060</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200502530</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grad</surname>
<given-names>L. I.</given-names>
</name>
<name>
<surname>Guest</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Yanai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pokrishevsky</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>O&#x27;Neill</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Gibbs</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Intermolecular transmission of superoxide dismutase 1 misfolding in living cells</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>108</volume> (<issue>39</issue>), <fpage>16398</fpage>&#x2013;<lpage>16403</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1102645108</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregoire</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Irwin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Techniques for monitoring protein misfolding and aggregation <italic>in vitro</italic> and in living cells</article-title>. <source>Korean J. Chem. Eng.</source> <volume>29</volume>, <fpage>693</fpage>&#x2013;<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1007/s11814-012-0060-x</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haq</surname>
<given-names>F. U.</given-names>
</name>
<name>
<surname>Abro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Raza</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liedl</surname>
<given-names>K. R.</given-names>
</name>
<name>
<surname>Azam</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Molecular dynamics simulation studies of novel &#x3b2;-lactamase inhibitor</article-title>. <source>J. Mol. Graph. Model.</source> <volume>74</volume>, <fpage>143</fpage>&#x2013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmgm.2017.03.002</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hawe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sutter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jiskoot</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Extrinsic fluorescent dyes as tools for protein characterization</article-title>. <source>Pharm. Res.</source> <volume>25</volume>, <fpage>1487</fpage>&#x2013;<lpage>1499</lpage>. <pub-id pub-id-type="doi">10.1007/s11095-007-9516-9</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Andr&#xe9;</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sandt</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Djian</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Synchrotron-based infrared spectroscopy brings to light the structure of protein aggregates in neurodegenerative diseases</article-title>. <source>Rev. Anal. Chem.</source> <volume>33</volume> (<issue>4</issue>), <fpage>231</fpage>&#x2013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1515/revac-2014-0016</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollingsworth</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Dror</surname>
<given-names>R. O.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Molecular dynamics simulation for all</article-title>. <source>Neuron</source> <volume>99</volume> (<issue>6</issue>), <fpage>1129</fpage>&#x2013;<lpage>1143</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.011</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hough</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Grossmann</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Antonyuk</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Strange</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Doucette</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>J. A.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>101</volume> (<issue>16</issue>), <fpage>5976</fpage>&#x2013;<lpage>5981</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0305143101</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>Y.-M.</given-names>
</name>
<name>
<surname>Stathopulos</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Dimmick</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Badiei</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>M. S.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Nonamyloid aggregates arising from mature copper/zinc superoxide dismutases resemble those observed in amyotrophic lateral sclerosis</article-title>. <source>J. Biol. Chem.</source> <volume>285</volume> (<issue>53</issue>), <fpage>41701</fpage>&#x2013;<lpage>41711</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.113696</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Idrees</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Naqvi</surname>
<given-names>A. A. T.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gourinath</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Insight into the conformational transitions of serine acetyl transferase isoforms in E. Histolytica: implications for structural and functional balance</article-title>. <source>ACS omega</source> <volume>7</volume> (<issue>28</issue>), <fpage>24626</fpage>&#x2013;<lpage>24637</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.2c02467</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Idrees</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Prakash</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>M. I.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>GdnHCl-induced unfolding intermediate in the mitochondrial carbonic anhydrase VA</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>91</volume>, <fpage>1151</fpage>&#x2013;<lpage>1160</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2016.06.080</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Idrees</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shahbaaz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Haque</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Estimation of thermodynamic stability of human carbonic anhydrase IX from urea-induced denaturation and MD simulation studies</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>105</volume>, <fpage>183</fpage>&#x2013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.07.010</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jahan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nayeem</surname>
<given-names>S. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Conformational dynamics of superoxide dismutase (SOD1) in osmolytes: a molecular dynamics simulation study</article-title>. <source>RSC Adv.</source> <volume>10</volume> (<issue>46</issue>), <fpage>27598</fpage>&#x2013;<lpage>27614</lpage>. <pub-id pub-id-type="doi">10.1039/d0ra02151b</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miotto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ness</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Opie-Martin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Spargo</surname>
<given-names>T. P.</given-names>
</name>
<name>
<surname>Di Rienzo</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Molecular dynamics analysis of superoxide dismutase 1 mutations suggests decoupling between mechanisms underlying ALS onset and progression</article-title>. <source>Comput. Struct. Biotechnol. J.</source> <volume>21</volume>, <fpage>5296</fpage>&#x2013;<lpage>5308</lpage>. <pub-id pub-id-type="doi">10.1016/j.csbj.2023.09.016</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamerzell</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Middaugh</surname>
<given-names>C. R.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>The complex inter-relationships between protein flexibility and stability</article-title>. <source>J. Pharm. Sci.</source> <volume>97</volume> (<issue>9</issue>), <fpage>3494</fpage>&#x2013;<lpage>3517</lpage>. <pub-id pub-id-type="doi">10.1002/jps.21269</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keerthana</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kolandaivel</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Study of mutation and misfolding of Cu-Zn SOD1 protein</article-title>. <source>J. Biomol. Struct. Dyn.</source> <volume>33</volume> (<issue>1</issue>), <fpage>167</fpage>&#x2013;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2013.865104</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khare</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>Dokholyan</surname>
<given-names>N. V.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Common dynamical signatures of familial amyotrophic lateral sclerosis-associated structurally diverse Cu, Zn superoxide dismutase mutants</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>103</volume> (<issue>9</issue>), <fpage>3147</fpage>&#x2013;<lpage>3152</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0511266103</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kostrzewa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Burck-Lehmann</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>M&#xfc;ller</surname>
<given-names>U.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Autosomal dominant amyotrophic lateral sclerosis: a novel mutation in the Cu/Zn superoxide dismutase-1 gene</article-title>. <source>Hum. Mol. Genet.</source> <volume>3</volume> (<issue>12</issue>), <fpage>2261</fpage>&#x2013;<lpage>2262</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/3.12.2261</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krimm</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bandekar</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins</article-title>. <source>Adv. protein Chem.</source> <volume>38</volume>, <fpage>181</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1016/s0065-3233(08)60528-8</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bhardwaj</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Purohit</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Explicit-solvent molecular dynamics simulations revealed conformational regain and aggregation inhibition of I113T SOD1 by Himalayan bioactive molecules</article-title>. <source>J. Mol. Liq.</source> <volume>339</volume>, <fpage>116798</fpage>. <pub-id pub-id-type="doi">10.1016/j.molliq.2021.116798</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Choudhry</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zamzami</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Sarwar Jamal</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Computing disease-linked SOD1 mutations: deciphering protein stability and patient-phenotype relations</article-title>. <source>Sci. Rep.</source> <volume>7</volume> (<issue>1</issue>), <fpage>4678</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-04950-9</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Consortium</surname>
<given-names>O. S. D. D.</given-names>
</name>
<name>
<surname>Lynn</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>g_mmpbsa&#xb7; A GROMACS tool for high-throughput MM-PBSA calculations</article-title>. <source>J. Chem. Inf. Model.</source> <volume>54</volume> (<issue>7</issue>), <fpage>1951</fpage>&#x2013;<lpage>1962</lpage>. <pub-id pub-id-type="doi">10.1021/ci500020m</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Panday</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Alexov</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>SAAFEC-SEQ: a sequence-based method for predicting the effect of single point mutations on protein thermodynamic stability</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume> (<issue>2</issue>), <fpage>606</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22020606</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maitham Qassim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baziyar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ahamady-Asbchin</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Polyphenolic flavonoid compounds act as the inhibitory potential of aggregation process: implications for the prevention and therapeutics against FALS-associated D101G SOD1 mutant</article-title>. <source>Comput. Biol. Chem.</source> <volume>107</volume>, <fpage>107967</fpage>. <pub-id pub-id-type="doi">10.1016/j.compbiolchem.2023.107967</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marklund</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marklund</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1974</year>). <article-title>Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase</article-title>. <source>Eur. J. Biochem.</source> <volume>47</volume> (<issue>3</issue>), <fpage>469</fpage>&#x2013;<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1974.tb03714.x</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mavadat</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hosseinkhani</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2023a</year>). <article-title>A double point mutation of SOD1 targeting net charge promotes aggregation under destabilizing conditions: correlation of charge distribution and ALS-provoking mutation</article-title>. <source>Biochimica Biophysica Acta (BBA)-General Subj.</source> <volume>1867</volume> (<issue>5</issue>), <fpage>130325</fpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2023.130325</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mavadat</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hosseinkhani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Colagar</surname>
<given-names>A. H.</given-names>
</name>
</person-group> (<year>2023b</year>). <article-title>Role of charged residues of the &#x201c;electrostatic loop&#x201d; of hSOD1 in promotion of aggregation: implications for the mechanism of ALS-associated mutations under amyloidogenic conditions</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>244</volume>, <fpage>125289</fpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2023.125289</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lazareva-Ulitsky</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Loo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kejariwal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vandergriff</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rabkin</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>The PANTHER database of protein families, subfamilies, functions and pathways</article-title>. <source>Nucleic acids Res.</source> <volume>33</volume> (<issue>Suppl. l_1</issue>), <fpage>D284</fpage>&#x2013;<lpage>D288</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gki078</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Bourassa</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R. J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>FTIR spectroscopic imaging of protein aggregation in living cells</article-title>. <source>Biochimica biophysica acta (BBA)-biomembranes</source> <volume>1828</volume> (<issue>10</issue>), <fpage>2339</fpage>&#x2013;<lpage>2346</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2013.01.014</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hashemi</surname>
<given-names>S. Z.</given-names>
</name>
<name>
<surname>Hosseinkhani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mohseni</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Implications of ALS-associated mutations on biochemical and biophysical features of hSOD1 and Aggregation Formation</article-title>. <source>Biochem. Genet.</source> <volume>62</volume>, <fpage>3658</fpage>&#x2013;<lpage>3680</lpage>. <pub-id pub-id-type="doi">10.1007/s10528-023-10619-y</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montanucci</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Capriotti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ben-Tal</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fariselli</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>DDGun: an untrained method for the prediction of protein stability changes upon single and multiple point variations</article-title>. <source>BMC Bioinforma.</source> <volume>20</volume>, <fpage>335</fpage>&#x2013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1186/s12859-019-2923-1</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nagano</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Masutani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fujiwara</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Urushitani</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS</article-title>. <source>Hum. Mol. Genet.</source> <volume>24</volume> (<issue>12</issue>), <fpage>3427</fpage>&#x2013;<lpage>3439</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddv093</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Namadyan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hosseinkhani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Baziyar</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Biochemical and biophysical properties of the novel ALS-linked hSOD1 mutants: an experimental study accompanied by <italic>in silico</italic> analysis</article-title>. <source>J. Iran. Chem. Soc.</source> <volume>20</volume> (<issue>1</issue>), <fpage>125</fpage>&#x2013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1007/s13738-022-02660-2</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>SIFT: predicting amino acid changes that affect protein function</article-title>. <source>Nucleic acids Res.</source> <volume>31</volume> (<issue>13</issue>), <fpage>3812</fpage>&#x2013;<lpage>3814</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noorbakhsh Varnosfaderani</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Sadat Haeri</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arian</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Yousefi Rad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yazdanpour</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mojahedian</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation</article-title>. <source>J. Biomol. Struct. Dyn.</source> <volume>43</volume>, <fpage>419</fpage>&#x2013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2023.2281641</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oztug Durer</surname>
<given-names>Z. A.</given-names>
</name>
<name>
<surname>Cohlberg</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Dinh</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Padua</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ehrenclou</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Downes</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase</article-title>. <source>PloS one</source> <volume>4</volume> (<issue>3</issue>), <fpage>e5004</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0005004</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papaleo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mereghetti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fantucci</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Grandori</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>De Gioia</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case</article-title>. <source>J. Mol. Graph. Model.</source> <volume>27</volume> (<issue>8</issue>), <fpage>889</fpage>&#x2013;<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmgm.2009.01.006</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>G. R. C.</given-names>
</name>
<name>
<surname>Tavares</surname>
<given-names>G. D. B.</given-names>
</name>
<name>
<surname>de Freitas</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>De Mesquita</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>
<italic>In silico</italic> analysis of the tryptophan hydroxylase 2 (TPH2) protein variants related to psychiatric disorders</article-title>. <source>PLoS One</source> <volume>15</volume> (<issue>3</issue>), <fpage>e0229730</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0229730</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereira</surname>
<given-names>G. R. C.</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>B. d.A. A.</given-names>
</name>
<name>
<surname>De Mesquita</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Comprehensive <italic>in silico</italic> analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis</article-title>. <source>PLoS One</source> <volume>16</volume> (<issue>2</issue>), <fpage>e0247841</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0247841</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Proteins: structure and Function. David Whitford. Chichester, West Sussex, England: john Wiley and Sons Ltd., 2005, 542 pp., paperback, $65.00. ISBN 0-471-49894-7</article-title>. <source>Clin. Chem.</source> <volume>51</volume> (<issue>11</issue>), <fpage>2220</fpage>&#x2013;<lpage>2221</lpage>. <pub-id pub-id-type="doi">10.1373/clinchem.2005.057588</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pettersen</surname>
<given-names>E. F.</given-names>
</name>
<name>
<surname>Goddard</surname>
<given-names>T. D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Couch</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Greenblatt</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>E. C.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>UCSF Chimera&#x2014;a visualization system for exploratory research and analysis</article-title>. <source>J. Comput. Chem.</source> <volume>25</volume> (<issue>13</issue>), <fpage>1605</fpage>&#x2013;<lpage>1612</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pires</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Blundell</surname>
<given-names>T. L.</given-names>
</name>
</person-group> (<year>2014a</year>). <article-title>DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach</article-title>. <source>Nucleic acids Res.</source> <volume>42</volume> (<issue>W1</issue>), <fpage>W314</fpage>&#x2013;<lpage>W319</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku411</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pires</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Blundell</surname>
<given-names>T. L.</given-names>
</name>
</person-group> (<year>2014b</year>). <article-title>mCSM: predicting the effects of mutations in proteins using graph-based signatures</article-title>. <source>Bioinformatics</source> <volume>30</volume> (<issue>3</issue>), <fpage>335</fpage>&#x2013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt691</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prudencio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Borchelt</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>P. M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease</article-title>. <source>Hum. Mol. Genet.</source> <volume>18</volume> (<issue>17</issue>), <fpage>3217</fpage>&#x2013;<lpage>3226</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp260</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raghuraman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Site-directed fluorescence approaches for dynamic structural biology of membrane peptides and proteins</article-title>. <source>Front. Mol. Biosci.</source> <volume>6</volume>, <fpage>96</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2019.00096</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rakhit</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chakrabartty</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis</article-title>. <source>Biochimica Biophysica Acta (BBA) - Mol. Basis Dis.</source> <volume>1762</volume> (<issue>11</issue>), <fpage>1025</fpage>&#x2013;<lpage>1037</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2006.05.004</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramensky</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sunyaev</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Human non&#x2010;synonymous SNPs: server and survey</article-title>. <source>Nucleic acids Res.</source> <volume>30</volume> (<issue>17</issue>), <fpage>3894</fpage>&#x2013;<lpage>3900</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkf493</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodrigues</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Pires</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>D. B.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>DynaMut2: Assessing changes in stability and flexibility upon single and multiple point missense mutations</article-title>. <source>Protein Sci.</source> <volume>30</volume> (<issue>1</issue>), <fpage>60</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1002/pro.3942</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosen</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Siddique</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Figlewicz</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Sapp</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hentati</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>1993</year>). <article-title>Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis</article-title>. <source>Nature</source> <volume>362</volume> (<issue>6415</issue>), <fpage>59</fpage>&#x2013;<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/362059a0</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saccon</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Bunton-Stasyshyn</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Fratta</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Is SOD1 loss of function involved in amyotrophic lateral sclerosis?</article-title> <source>Brain</source> <volume>136</volume> (<issue>8</issue>), <fpage>2342</fpage>&#x2013;<lpage>2358</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awt097</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Joye</surname>
<given-names>I. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Peak fitting applied to fourier transform infrared and raman spectroscopic analysis of proteins</article-title>. <source>Appl. Sci.</source> <volume>10</volume> (<issue>17</issue>), <fpage>5918</fpage>. <pub-id pub-id-type="doi">10.3390/app10175918</pub-id>
</citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salehi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nikkhah</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ghasemi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Arab</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Mitochondrial membrane disruption by aggregation products of ALS-causing superoxide dismutase-1 mutants</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>75</volume>, <fpage>290</fpage>&#x2013;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.01.022</pub-id>
</citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandelin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nordlund</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Marklund</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Oliveberg</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Amyotrophic lateral sclerosis-associated copper/zinc superoxide dismutase mutations preferentially reduce the repulsive charge of the proteins</article-title>. <source>J. Biol. Chem.</source> <volume>282</volume> (<issue>29</issue>), <fpage>21230</fpage>&#x2013;<lpage>21236</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M700765200</pub-id>
</citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinivasan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rajasekaran</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Exploring the cause of aggregation and reduced Zn binding affinity by G85R mutation in SOD1 rendering amyotrophic lateral sclerosis</article-title>. <source>Proteins Struct. Funct. Bioinforma.</source> <volume>85</volume> (<issue>7</issue>), <fpage>1276</fpage>&#x2013;<lpage>1286</lpage>. <pub-id pub-id-type="doi">10.1002/prot.25288</pub-id>
</citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinivasan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rajasekaran</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Deciphering the loss of metal binding due to mutation D83G of human SOD1 protein causing FALS disease</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>107</volume>, <fpage>521</fpage>&#x2013;<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2017.09.019</pub-id>
</citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Srinivasan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rajasekaran</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Computational investigation on electrostatic loop mutants instigating destabilization and aggregation on human SOD1 protein causing amyotrophic lateral sclerosis</article-title>. <source>Protein J.</source> <volume>38</volume>, <fpage>37</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1007/s10930-018-09809-0</pub-id>
</citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stone</surname>
<given-names>E. A.</given-names>
</name>
<name>
<surname>Sidow</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity</article-title>. <source>Genome Res.</source> <volume>15</volume> (<issue>7</issue>), <fpage>978</fpage>&#x2013;<lpage>986</lpage>. <pub-id pub-id-type="doi">10.1101/gr.3804205</pub-id>
</citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strange</surname>
<given-names>R. W.</given-names>
</name>
<name>
<surname>Antonyuk</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hough</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Doucette</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>P. J.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>The structure of holo and metal-deficient wild-type human Cu, Zn superoxide dismutase and its relevance to familial amyotrophic lateral sclerosis</article-title>. <source>J. Mol. Biol.</source> <volume>328</volume> (<issue>4</issue>), <fpage>877</fpage>&#x2013;<lpage>891</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-2836(03)00355-3</pub-id>
</citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nishiyama</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Warita</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy</article-title>. <source>J. Hum. Genet.</source> <volume>68</volume> (<issue>3</issue>), <fpage>131</fpage>&#x2013;<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1038/s10038-022-01055-8</pub-id>
</citation>
</ref>
<ref id="B95">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Brown Jr</surname>
<given-names>R. H.</given-names>
</name>
<name>
<surname>Cleveland</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Decoding ALS: from genes to mechanism</article-title>. <source>Nature</source> <volume>539</volume> (<issue>7628</issue>), <fpage>197</fpage>&#x2013;<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1038/nature20413</pub-id>
</citation>
</ref>
<ref id="B96">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teilum</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Kragelund</surname>
<given-names>B. B.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Protein stability, flexibility and function</article-title>. <source>Biochimica Biophysica Acta (BBA)-Proteins Proteomics</source> <volume>1814</volume> (<issue>8</issue>), <fpage>969</fpage>&#x2013;<lpage>976</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbapap.2010.11.005</pub-id>
</citation>
</ref>
<ref id="B97">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiwari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hayward</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction</article-title>. <source>J. Biol. Chem.</source> <volume>278</volume> (<issue>8</issue>), <fpage>5984</fpage>&#x2013;<lpage>5992</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M210419200</pub-id>
</citation>
</ref>
<ref id="B98">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiwari</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>H&#xe4;gglund</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>M&#xf8;ller</surname>
<given-names>I. M.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Bjerrum</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Copper ion/H2O2 oxidation of Cu/Zn-Superoxide dismutase: Implications for enzymatic activity and antioxidant action</article-title>. <source>Redox Biol.</source> <volume>26</volume>, <fpage>101262</fpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2019.101262</pub-id>
</citation>
</ref>
<ref id="B99">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tompa</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Kadhirvel</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Changes in hydrophobicity mainly promotes the aggregation tendency of ALS associated SOD1 mutants</article-title>. <source>Int. J. Biol. Macromol.</source> <volume>145</volume>, <fpage>904</fpage>&#x2013;<lpage>913</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.09.181</pub-id>
</citation>
</ref>
<ref id="B100">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tompa</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Muthusamy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Srikanth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kadhirvel</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Molecular dynamics of far positioned surface mutations of Cu/Zn SOD1 promotes altered structural stability and metal-binding site: Structural clues to the pathogenesis of amyotrophic lateral sclerosis</article-title>. <source>J. Mol. Graph. Model.</source> <volume>100</volume>, <fpage>107678</fpage>. <pub-id pub-id-type="doi">10.1016/j.jmgm.2020.107678</pub-id>
</citation>
</ref>
<ref id="B101">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tosstorff</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Svilenov</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>G. H.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Structure-based discovery of a new protein-aggregation breaking excipient</article-title>. <source>Eur. J. Pharm. Biopharm.</source> <volume>144</volume>, <fpage>207</fpage>&#x2013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpb.2019.09.010</pub-id>
</citation>
</ref>
<ref id="B102">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trist</surname>
<given-names>B. G.</given-names>
</name>
<name>
<surname>Hilton</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Hare</surname>
<given-names>D. J.</given-names>
</name>
<name>
<surname>Crouch</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Double</surname>
<given-names>K. L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Superoxide dismutase 1 in health and disease: how a frontline antioxidant becomes neurotoxic</article-title>. <source>Angew. Chem. Int. Ed.</source> <volume>60</volume> (<issue>17</issue>), <fpage>9215</fpage>&#x2013;<lpage>9246</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202000451</pub-id>
</citation>
</ref>
<ref id="B103">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valentine</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Doucette</surname>
<given-names>P. A.</given-names>
</name>
<name>
<surname>Zittin Potter</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis</article-title>. <source>Annu. Rev. Biochem.</source> <volume>74</volume> (<issue>1</issue>), <fpage>563</fpage>&#x2013;<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.biochem.72.121801.161647</pub-id>
</citation>
</ref>
<ref id="B104">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Der Spoel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lindahl</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Groenhof</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mark</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Berendsen</surname>
<given-names>H. J.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>GROMACS: fast, flexible, and free</article-title>. <source>J. Comput. Chem.</source> <volume>26</volume> (<issue>16</issue>), <fpage>1701</fpage>&#x2013;<lpage>1718</lpage>. <pub-id pub-id-type="doi">10.1002/jcc.20291</pub-id>
</citation>
</ref>
<ref id="B105">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vascon</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gasparotto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giacomello</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cendron</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bergantino</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Filippini</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Protein electrostatics: From computational and structural analysis to discovery of functional fingerprints and biotechnological design</article-title>. <source>Comput. Struct. Biotechnol. J.</source> <volume>18</volume>, <fpage>1774</fpage>&#x2013;<lpage>1789</lpage>. <pub-id pub-id-type="doi">10.1016/j.csbj.2020.06.029</pub-id>
</citation>
</ref>
<ref id="B106">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vivian</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Callis</surname>
<given-names>P. R.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Mechanisms of tryptophan fluorescence shifts in proteins</article-title>. <source>Biophysical J.</source> <volume>80</volume> (<issue>5</issue>), <fpage>2093</fpage>&#x2013;<lpage>2109</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(01)76183-8</pub-id>
</citation>
</ref>
<ref id="B107">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J. Z.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>End-point binding free energy calculation with MM/PBSA and MM/GBSA: strategies and applications in drug design</article-title>. <source>Chem. Rev.</source> <volume>119</volume> (<issue>16</issue>), <fpage>9478</fpage>&#x2013;<lpage>9508</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.9b00055</pub-id>
</citation>
</ref>
<ref id="B108">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wise-Scira</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Dunn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Aloglu</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Sakallioglu</surname>
<given-names>I. T.</given-names>
</name>
<name>
<surname>Coskuner</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Structures of the E46K mutant-type &#x3b1;-synuclein protein and impact of E46K mutation on the structures of the wild-type &#x3b1;-synuclein protein</article-title>. <source>ACS Chem. Neurosci.</source> <volume>4</volume> (<issue>3</issue>), <fpage>498</fpage>&#x2013;<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1021/cn3002027</pub-id>
</citation>
</ref>
<ref id="B109">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Antonyuk</surname>
<given-names>S. V.</given-names>
</name>
<name>
<surname>Hasnain</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis</article-title>. <source>Q. Rev. biophysics</source> <volume>52</volume>, <fpage>e12</fpage>. <pub-id pub-id-type="doi">10.1017/S003358351900012X</pub-id>
</citation>
</ref>
<ref id="B110">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Biancalana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koide</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shea</surname>
<given-names>J.-E.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Binding modes of thioflavin-T to the single-layer beta-sheet of the peptide self-assembly mimics</article-title>. <source>J. Mol. Biol.</source> <volume>394</volume> (<issue>4</issue>), <fpage>627</fpage>&#x2013;<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2009.09.056</pub-id>
</citation>
</ref>
<ref id="B111">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L.-Q.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>X.-L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.-Q.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The free energy landscape of protein folding and dynamics: a global view</article-title>. <source>J. Biomol. Struct. Dyn.</source> <volume>31</volume> (<issue>9</issue>), <fpage>982</fpage>&#x2013;<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2012.748536</pub-id>
</citation>
</ref>
<ref id="B112">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaji</surname>
<given-names>H. D.</given-names>
</name>
<name>
<surname>Seyedalipour</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hanun</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Baziyar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hosseinkhani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Akhlaghi</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Computational insight into <italic>in silico</italic> analysis and molecular dynamics simulation of the dimer interface residues of ALS-linked hSOD1 forms in apo/holo states: a combined experimental and bioinformatic perspective</article-title>. <source>3 Biotech.</source> <volume>13</volume> (<issue>3</issue>), <fpage>92</fpage>. <pub-id pub-id-type="doi">10.1007/s13205-023-03514-1</pub-id>
</citation>
</ref>
<ref id="B113">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Schafer</surname>
<given-names>N. P.</given-names>
</name>
<name>
<surname>Wolynes</surname>
<given-names>P. G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Free energy landscapes for initiation and branching of protein aggregation</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>110</volume> (<issue>51</issue>), <fpage>20515</fpage>&#x2013;<lpage>20520</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1320483110</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>